Firsthand Technology Value Fund (SVVC) 10-Q 14 May 24 2024 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information	3 Months Ended
	Mar. 31, 2024 shares
Document Information [Line Items]
Entity Central Index Key	0001495584
Entity Registrant Name	Firsthand Technology Value Fund, Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	333-168195
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	27-3008946
Entity Address, Address Line One	150 Almaden Boulevard, Suite 1250
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95113
City Area Code	408
Local Phone Number	886-7096
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, $0.001 par value per share
Entity Common Stock, Shares Outstanding	6,893,056
No Trading Symbol Flag	true

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities (Unaudited) - USD ($)		Mar. 31, 2024	Dec. 31, 2023
ASSETS
Investment owned, cost		$ 133,837,406	$ 133,967,669
Investment, percent of net assets	[1]	4,695,742	8,733,779
Foreign currency at value (cost $2,629 and 2,629)		2,644	2,765
Receivable from dividends and interest		10,421	8,161
Other assets		38,374	63,649
Total Assets		4,747,181	8,808,354
LIABILITIES
Due to Custodian		277	0
Payable to affiliates (Note 4)		4,183,706	7,183,782
Trustees’ fees payable		37,504	13,891
Consulting fee payable		43,000	43,000
Accrued expenses and other payables		314,774	307,310
Total Liabilities		4,579,261	7,547,983
NET ASSETS		167,920	1,260,371
Net Assets consist of:
Common Stock, par value $0.001 per share 100,000,000 shares authorized		(6,893)	(6,893)
Paid-in-capital		176,770,722	176,770,722
Total distributable earnings (loss)		(176,609,695)	(175,517,244)
NET ASSETS		$ 167,920	$ 1,260,371
Shares of Common Stock outstanding (in shares)		7,016,432	7,016,432
Shares of Treasury Stock outstanding (in shares)		(123,376)	(123,376)
Net asset value per share (Note 2) (in dollars per share)		$ 0.02	$ 0.18
Investment, Unaffiliated Issuer [Member]
ASSETS
Investment owned, cost	[2]	$ 1,043,239	$ 1,173,502
Investment, percent of net assets	[2]	43,239	173,502
Investment, Affiliated Issuer [Member]
ASSETS
Investment owned, cost		662,235	662,235
Investment, percent of net assets		294,836	299,932
Investment, Affiliated Issuer, Controlled [Member]
ASSETS
Investment owned, cost		132,131,932	132,131,932
Investment, percent of net assets		$ 4,357,667	$ 8,260,345
[1]Includes warrants whose primary risk exposure is equity contracts.[2]Includes Fidelity Investment Money Market Treasury Portfolio - Class I, which invests primarily in U.S. Treasury securities. The yields as of 03/31/24 and 12/31/23 were 5.19% and 5.23%, respectively. Please see https://fundresearch.fidelity.com/mutual-funds/summary/316175504 for additional information.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Unaudited) (Parentheticals) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Foreign currency at cost	$ 2,629	$ 2,629
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Investment, Unaffiliated Issuer [Member]
Investment owned, cost yield	5.19%	5.23%

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
INVESTMENT INCOME
TOTAL INVESTMENT INCOME		$ 32,045	$ 191,262
EXPENSES
Investment advisory fees (Note 4)		33,703	192,820
Administration fees		29,026	28,503
Custody fees		1,043	2,160
Transfer agent fees		5,404	7,878
Registration and filing fees		8,813	8,704
Professional fees		67,815	65,769
Printing fees		21,037	14,548
Trustees fees		36,113	18,750
Compliance fees		27,509	29,288
Miscellaneous fees		19,813	20,931
TOTAL GROSS EXPENSES		250,276	389,351
Less waiver and/or reimbursement (Note 4)		(3,033,703)	0
TOTAL NET EXPENSES		(2,783,427)	389,351
NET INVESTMENT INCOME/(LOSS)		2,815,472	(198,089)
Net realized gains (losses) from security transactions on:
Net realized gains (losses)		0	(7,864,997)
Net change in unrealized appreciation (depreciation) on:
Net change in unrealized appreciation (depreciation)		(3,907,923)	3,320,862
Net Realized and Unrealized (Loss) on Investments		(3,907,923)	(4,544,135)
Net decrease in net assets from operations		$ (1,092,451)	$ (4,742,224)
Net Decrease In Net Assets Per Share Resulting From Operations (2) (in dollars per share)	[1]	$ (0.16)	$ (0.69)
Investment, Unaffiliated Issuer [Member]
INVESTMENT INCOME
Interest		$ 2,045	$ 42,279
Investment, Affiliated Issuer and Controlled1 [Member]
INVESTMENT INCOME
Interest		30,000	148,983
Investment, Affiliated Issuer and Controlled [Member]
INVESTMENT INCOME
Interest		30,000
Net realized gains (losses) from security transactions on:
Securities, realized gain (loss)		0	(7,864,997)
Net realized gains (losses)		0
Net change in unrealized appreciation (depreciation) on:
Affiliated/controlled investments and foreign currency		(3,907,923)	2,557,271
Affiliated/controlled warrants investments (1)	[2]	0	$ 763,591
Net change in unrealized appreciation (depreciation)		$ (3,907,774)
[1]Per share results are calculated based on weighted average shares outstanding for each period.[2]Primary exposure is equity risk.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net increase (decrease) in Net Assets resulting from operations	$ (1,092,451)	$ (4,742,224)
Adjustments to reconcile net increase (decrease) in Net Assets derived from operations to net cash provided by (used in) operating activities
Proceeds from disposition of investments	100,000	498,424
Net purchases/sales from short-term investments	30,114	(282,470)
Increase (decrease) in dividends, interest, and reclaims receivable	(2,260)	(168,314)
Increase (decrease) in due to Custodian	277	10,000
Increase (decrease) in payable to affiliates	(3,000,076)	222,107
Increase (decrease) in other assets	25,275	(8,563)
Increase (decrease) in accrued expenses and other payables	31,077	(73,157)
Net realized gain (loss) from investments	0	7,864,997
Net unrealized appreciation (depreciation) from investments, other assets, and warrants transactions	3,907,923	(3,320,862)
Net cash provided by (used in) operating activities	(121)	(62)
CASH FLOWS FROM FINANCING ACTIVITIES
Net cash provided by financing activities	0	0
Net increase (decrease) in cash	(121)	(62)
Cash and foreign currency - beginning of period	2,765	3,404
Cash and foreign currency - end of period	$ 2,644	$ 3,342

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
FROM OPERATIONS:
Net investment income (loss)	$ 2,815,472	$ (198,089)
Net realized gain (loss) from security transactions and foreign currency	0	(7,864,997)
Net change in unrealized appreciation (depreciation) on investments	(3,907,923)	3,320,862
Net decrease in net assets from operations	(1,092,451)	(4,742,224)
TOTAL DECREASE IN NET ASSETS	(1,092,451)	(4,742,224)
NET ASSETS:
Beginning of period	1,260,371	30,609,591
End of period	$ 167,920	$ 25,867,367
COMMON STOCK ACTIVITY:
Shares repurchased (in shares)	0	0
Net increase in shares outstanding (in shares)	0	0
Shares outstanding, beginning of period (in shares)	6,893,056	6,893,056
Total Shares of Common Stock outstanding (in shares)	6,893,056	6,893,056

Consolidated Financial Highligh

Consolidated Financial Highlights	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investment Company, Financial Highlights [Text Block]	Consolidated Financial Highlights Selected per share data and ratios for a share outstanding throughout each period FOR THE THREE FOR THE FOR THE FOR THE FOR THE FOR THE Net asset value at beginning of period $ 0.18 $ 4.44 $ 13.75 $ 14.82 $ 17.70 $ 26.69 Income from investment operations: Net investment income (loss), before deferred taxes 0.41 0.16 (1.81 ) 0.44 (1) 0.09 (1) 0.90 (1) Deferred tax benefit — — — — — (0.08 ) Net investment gain (losses) 0.41 0.16 (1.81 ) 0.44 0.09 0.82 Net realized and unrealized gains (losses) on investments, before deferred taxes (0.57 ) (4.42 ) (7.50 ) (1.51 ) (2.30 ) (12.15 ) Deferred tax expense — — — — (1.13 ) 2.34 Net realized and unrealized gains (losses) on investments, after deferred taxes (0.57 ) (4.42 ) (7.50 ) (1.51 ) (3.43 ) (9.81 ) Total from investment operations (0.16 ) (4.26 ) (9.31 ) (1.07 ) (3.34 ) (8.99 ) Distributions from: Realized capital gains — — — — — — Anti-dilutive effect from capital share transactions — — — — 0.46 — Net asset value at end of period $ 0.02 $ 0.18 $ 4.44 $ 13.75 $ 14.82 $ 17.70 Market value at end of period $ 0.26 $ 0.30 $ 0.95 $ 4.01 $ 4.47 $ 6.43 Total Return Based on Net Asset Value (88.89 )% (A) (95.95 )% (67.71 )% (7.22 )% (16.27 )% (33.68 )% Based on Market Value (13.33 )% (A) (68.42 )% (76.31 )% (10.29 )% (30.48 )% (42.59 )% Net assets at end of period (millions) $ 0.2 $ 1.3 $ 30.6 $ 94.8 $ 102.1 $ 127.1 See accompanying notes to financial statements Firsthand Technology Value Fund, Inc. Consolidated Financial Highlights - continued Selected per share data and ratios for a share outstanding throughout each period FOR THE THREE MONTHS ENDED FOR THE FOR THE FOR THE FOR THE FOR THE MARCH 31, YEAR ENDED YEAR ENDED YEAR ENDED YEAR ENDED YEAR ENDED 2024 DECEMBER 31, DECEMBER 31, DECEMBER 31, DECEMBER 31, DECEMBER 31, (Unaudited) 2023 2022 2021 2020 2019 Ratio of total expenses to average net assets: Before tax (benefit)/expense (1567.59 )% (B) (7.21 )% 4.11 % 3.12 % 3.10 % (2.84 )% (2) Deferred tax (benefit)/expense (3)(4) — — — — 8.02 % (5) (9.91 )% Total expenses (1567.59 )% (B) (7.21 )% 4.11 % 3.12 % 11.12 % (12.75 )% (2) Total expenses, excluding incentive fees and deferred tax expense (1567.59 )% (B) (7.21 )% 4.11 % 3.12 % 3.10 % 2.80 % Total expenses, excluding incentive fees, deferred tax expense and fee waiver 140.95 % (B) 11.91 % 4.11 % 3.12 % 3.10 % 2.80 % Ratio of net investment income (loss) to average net assets: Before tax benefit 1585.64 % (B) 8.13 % (20.96 )% 2.94 % 0.64 % 3.93 % (2) Deferred tax benefit (4)(6) — — — — — (0.33 )% Net investment income (loss) 1585.64 % (B) 8.13 % (20.96 )% 2.94 % 0.64 % 3.60 % Net investment income before fee waiver (122.90 )% (B) (10.99 )% (20.96 )% 2.94 % 0.64 % 3.60 % Portfolio turnover rate 0 % (A)(C) 1 % 15 % 16 % 13 % 18 % ( 1 Calculated using average shares outstanding. ( 2 Amount includes the incentive fee. For the year ended December 31, 2019, ( 3 Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses). ( 4 The deferred tax expense and tax benefit are based on average net assets. ( 5 As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense. ( 6 Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only. (A) Not (B) Annualized. (C) Less than 1% See accompanying notes to financial statements

Consolidated Schedule of Invest

Consolidated Schedule of Investments	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investment Holdings [Text Block]	Consolidated Schedule of Investments MARCH 31, 2024 ( PORTFOLIO COMPANY (% OF NET ASSETS) Interest SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT Maturity Rate ACQUISITION DATE VALUE ($) COST BASIS VALUE EQX CAPITAL, INC. ( 37.6 Equipment Leasing Common Stock *(1)(2)(4) 6/10/2016 100,000 $ 20,000 $ 9 Preferred Stock - Series A *(1)(2)(4) 6/10/2016 - 11/7/2016 1,950,000 1,950,000 63,148 63,157 HERA SYSTEMS, INC. ( 1880.9 Aerospace Convertible Note (1)(2)(4)(6) 12/31/2024 10% 12/29/2022 5,359,791 5,359,791 2,580,617 Convertible Note (1)(2)(4) 12/31/2024 10% 12/29/2022 1,200,000 1,200,000 577,772 Preferred Stock - Series A *(1)(2)(4) 9/18/2015 3,642,324 2,000,000 0 Preferred Stock - Series B *(1)(2)(4) 8/7/2017 - 2/1/2019 7,039,203 6,587,102 0 Preferred Stock - Series C *(1)(2)(4) 8/7/2019 - 2/12/2020 2,650,000 2,650,000 0 Preferred Stock Warrants - Series B *(1)(2)(4) 7/9/2018 - 9/4/2018 12,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 2/1/2019 5,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 8/7/2017 6,214,922 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 9/28/2017 700,000 0 0 3,158,389 INTRAOP MEDICAL CORP. ( 74.7 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/11/2019 500,000 500,000 2,255 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/22/2021 1,000,000 1,000,000 4,511 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/29/2019 500,000 500,000 2,255 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT Maturity Interest Rate ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/6/2021 500,000 $ 500,000 $ 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/12/2021 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/29/2021 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 12/31/2018 10,961,129 10,961,129 49,448 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/27/2020 1,000,000 1,000,000 4,511 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/28/2022 200,000 200,000 902 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/252020 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/30/2022 150,000 150,000 677 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/20/2021 1,000,000 1,000,000 4,511 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/6/2022 350,000 350,000 1,579 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/8/2020 400,000 400,000 1,804 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2021 500,000 500,000 2,256 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2022 700,000 $ 700,000 $ 3,158 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/12/2019 1,300,000 1,300,000 5,864 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/16/2021 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/31/2020 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 8/28/2020 750,000 750,000 3,383 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 9/22/2021 500,000 500,000 2,256 Preferred Stock - Series C *(1)(2)(4) 7/12/2013 26,856,187 26,299,939 0 Term Note (1)(2)(4)(6) 12/31/2024 8% 2/10/2017 2,000,000 2,000,000 9,022 Term Note (1)(2)(4)(6) 12/31/2024 8% 2/28/2014 3,000,000 3,000,000 13,534 125,462 LYNCEAN TECHNOLOGIES, INC. ( 0.0 Semiconductor Equipment Preferred Stock - Series B *(1)(4) 7/3/2018 869,792 1,000,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE REVASUM, INC. ( 601.9 Semiconductor Equipment CDIs *(2)(4) 11/14/2016 - 10/3/2022 39,774,889 $ 9,268,218 $ 1,010,659 UCT COATINGS, INC. ( 175.6 Advanced Materials Common Stock *(1)(3)(4) 4/18/2011 1,500,000 662,235 294,836 WRIGHTSPEED, INC. ( 0.0 Automotive Common Stock *(1)(2)(4) 6/7/2019 69,102 7,460,851 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 1/10/2023 100,000 100,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/23/2020 1,050,000 1,050,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/20/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/21/2022 135,000 135,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/5/2021 700,000 700,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/11/2020 400,000 400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/14/2022 165,000 165,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/23/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/24/2020 375,000 375,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/11/2020 400,000 $ 400,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/23/2020 2,000,000 2,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/28/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/9/2022 125,000 125,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2021 1,400,000 1,400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2022 200,000 200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 3/11/2022 185,000 185,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/12/2021 1,200,000 1,200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/14/2022 65,000 65,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/10/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5//18/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/26/2022 250,000 250,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/10/2022 250,000 $ 250,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/22/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/28/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/7/2019 4,929,015 4,929,015 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/13/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/26/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/28/ 2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2020 750,000 750,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/19/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/10/2022 900,000 900,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/22/2021 300,000 300,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 18% 7/25/2023 40,000 $ 40,000 $ 0 Preferred Stock - Series AA *(1)(2)(4) 6/7/2019 - 7/20/2020 60,733,693 17,355,887 0 0 INVESTMENT COMPANY ( 25.7 Fidelity Investments Money Market Treasury Portfolio - Class I (5) Various 43,239 43,239 43,239 TOTAL INVESTMENTS (Cost $ 133,837,406 2796.4 $ 4,695,742 LIABILITIES IN EXCESS OF OTHER ASSETS — ( 2696.4 (4,527,822 ) NET ASSETS — 100.0 $ 167,920 All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments. CDI: CHESS Depositary Interests * Non-income producing security. ( 1 Restricted security. Fair Value is determined by or under the direction of the Company s Board of Directors (see Note 3 March 31, 2024, 2 ( 2 Controlled investments. ( 3 Affiliated issuer. ( 4 Fair Value Level 3 ( 5 The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities. ( 6 Security whose interest accrues until maturity however, based on March 31, 2024 no March 31, 2024. See accompanying notes to financial statements Firsthand Technology Value Fund, Inc. Consolidated Schedule of Investments - continued DECEMBER 31, 2023 PORTFOLIO COMPANY (% OF NET ASSETS) INTEREST SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE EQX CAPITAL, INC. ( 8.8 Common Stock *(1)(2)(4) June 10, 2016 100,000 $ 20,000 $ 55 Equipment Leasing Preferred Stock - Series A *(1)(2)(4) June 10, 2016 - 11/72016 1,950,000 1,950,000 110,172 110,227 HERA SYSTEMS, INC. ( 333.2 Convertible Note (1)(2)(4) 12/31/2024 10% 12/29/2022 1,200,000 1,200,000 768,317 Convertible Note (1)(2)(4)(6) 12/31/2024 10% 12/29/2022 5,359,791 5,359,791 3,431,683 Preferred Stock - Series A *(1)(2)(4) 9/18/2015 3,642,324 2,000,000 0 Preferred Stock - Series B *(1)(2)(4) 8/7/2017 - 2/1/2019 7,039,203 6,587,102 0 Preferred Stock - Series C *(1)(2)(4) 8/7/2019 - 2/12/2020 2,650,000 2,650,000 0 Preferred Stock Warrants - Series B *(1)(2)(4) 7/9/2018 - 9/4/2018 12,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 2/1/2019 5,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 8/7/2017 6,214,922 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 9/28/2017 700,000 0 0 4,200,000 INTRAOP MEDICAL CORP. ( 7.0 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 12/31/2018 10,961,129 10,961,129 34,570 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/12/2019 1,300,000 1,300,000 4,100 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/11/2019 500,000 500,000 1,577 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/29/2019 500,000 $ 500,000 $ 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/27/2020 1,000,000 1,000,000 3,154 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/25/2020 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 5/8/2020 400,000 400,000 1,261 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/31/2020 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/28/2020 750,000 750,000 2,365 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/20/2021 1,000,000 1,000,000 3,154 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/16/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 9/22/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/6/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/22/2021 1,000,000 1,000,000 3,154 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/12//2021 500,000 $ 500,000 $ 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/29/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/28/2022 200,000 200,000 631 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/30/2022 150,000 150,000 473 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/6/2022 350,000 350,000 1,104 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2022 700,000 700,000 2,208 Preferred Stock - Series C *(1)(2)(4) 7/12/2013 26,856,187 26,299,938 0 Term Note Matures (1)(2)(4)(6) 12/31/2024 8% 2/28/2014 3,000,000 3,000,000 9,461 Term Note Matures (1)(2)(4)(6) 12/31/2024 8% 2/10/2017 2,000,000 2,000,000 6,308 87,713 KYMA, INC. ( 7.9 Advanced Materials Convertible Note (1)(4) 3/30/2024 10% 3/1//2019 100,000 100,000 100,000 LYNCEAN TECHNOLOGIES, INC. ( 0.0 Preferred Stock - Series B *(1)(4) 7/3/2018 869,792 1,000,000 0 Semiconductor Equipment See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE REVASUM, INC. ( 306.5 CDIs *(2) 11/14/2016 - 10/3/2022 39,774,889 $ 9,268,219 $ 3,862,405 Semiconductor Equipment UCT COATINGS, INC. ( 23.8 Common Stock *(1)(3)(4) 4/18/2011 1,500,000 662,235 299,932 Advanced Materials WRIGHTSPEED, INC. ( 0.0 Common Stock *(1)(2)(4) 4/11/2013 - 5/6//2019 69,102 7,460,851 0 Automotive Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/7/2019 4,929,015 4,929,015 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2020 750,000 750,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/10/2020 900,000 900,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/13/2020 1,050,000 1,050,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/11/2020 400,000 400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/24/2020 375,000 375,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/11/2020 400,000 400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/23/2020 2,000,000 2,000,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2021 1,400,000 1,400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/12/2021 1,200,000 1,200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/18/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/22/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/26/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/19/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/22/2021 300,000 300,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/5/2021 700,000 $ 700,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/20/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/23/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/28/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2022 200,000 200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 3/11/2022 185,000 185,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/14/2022 65,000 65,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/10/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/26/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/10/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/28/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/13/2022 250,000 250,000 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/28/2022 250,000 $ 250,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/21/2022 135,000 135,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/14/2022 165,000 165,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/9/2022 125,000 125,000 0 Preferred Stock - Series AA *(1)(2)(4) 6/7/2019 - 7/20/2020 60,733,693 17,355,887 0 Preferred Stock Warrants - Series AA *(1)(2)(4) 6/7/2019 609,756 0 0 0 See accompanying notes to financial statements PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT ACQUISITION DATE VALUE ($) COST BASIS VALUE INVESTMENT COMPANY (5.8 Fidelity Investments Money Market Treasury Portfolio - Class I (5) Various 73,502 $ 73,502 $ 73,502 TOTAL INVESTMENTS (Cost $ 133,967,669 693.0 $ 8,733,779 LIABILITIES IN EXCESS OF OTHER ASSETS ( 593.0 (7,473,408 ) NET ASSETS 100.0 $ 1,260,371 All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments. CDI: CHESS Depositary Interest. * Non-income producing security. ( 1 Restricted security. Fair Value is determined by or under the direction of the Company s Board of Directors (See note 3 December 31, 2023, 2 ( 2 Controlled investments. ( 3 Affiliated issuer. ( 4 Fair Value Level 3 ( 5 The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities. ( 6 Security whose interest accrues until maturity however, based on December 31, 2023 no December 31, 2023. See accompanying notes to financial statements

Note 1 - The Company

Note 1 - The Company	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Firsthand Technology Value Fund, Inc. (the “Company,” the “Fund,” “us,” “our,” and “we”), is a Maryland corporation and an externally managed, non-diversified, closed-end management investment company that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, “1940 April 15, 2011. April 18th, 2011. not no $250 September 30. 2023 September 30, October 6, 2023, The Company is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946. CONSOLIDATION OF SUBSIDIARIES. May 8, 2015, 1940 March 30, 2015. June 30, 2015, July 1, 2015. During the fiscal years ended December 31, 2016 2017, three 1940 one not The Board of Directors of the Company approved the liquidation of those three November 2, 2018. December 27, 2018.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2. The following is a summary of significant accounting policies followed in the preparation of the Company’s financial statements included in this report: BASIS OF PRESENTATION. 10 946, Financial Services Investment Companies 946” 6, 10 12 X. Under the 1940 946, 6 X, December 31, 2018, no USE OF ESTIMATES. PORTFOLIO INVESTMENT VALUATIONS. 1940 2 41 1940 March 31, 2024, may 6 CASH AND CASH EQUIVALENTS. three RESTRICTED SECURITIES. March 31. 2024, December 31, 2023, INCOME RECOGNITION. SHARE VALUATION. REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS. INCOME TAXES. FOREIGN CURRENCY TRANSLATION. not may SECURITIES TRANSACTIONS. CONCENTRATION OF CREDIT RISK. may OPTIONS. may may may Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. DEFERRED COMPENSATION. December 26, 2022, March 31, 2024, January 1, 2025 The average monthly volume of the Company’s derivatives during the three March 31, 2024 PURCHASED OPTIONS WARRANTS (NOTIONAL WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — — —

Note 3 - Business Risks and Unc

Note 3 - Business Risks and Uncertainties	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Unusual Risks and Uncertainties Disclosure [Text Block]	NOTE 3. We invest a substantial portion of our assets in privately-held companies, the securities of which are inherently illiquid. We also seek to invest in small publicly-traded companies that we believe have exceptional growth potential and to make opportunistic investments in publicly-traded companies, both large and small. In the case of investments in small publicly-traded companies, although these companies are publicly traded, their stock may not may may no not We do not not one may may Because there is typically no not 2 19 1940 may one may The Board has engaged an independent valuation firm to provide it with valuation assistance with respect to certain of our portfolio investments. The Company intends to continue to engage an independent valuation firm to provide us with assistance regarding our determination of the fair value of select portfolio investments each quarter unless directed by the Board to cancel such valuation services. The scope of the services rendered by an independent valuation firm is at the discretion of the Board. The Board is ultimately and solely responsible for determining the fair value of the Company’s investments in good faith. With respect to investments for which market quotations are not not ( 1 each quarter the valuation process begins with each portfolio company or investment being initially valued by the Advisor’s Valuation Committee or the independent valuation firm; ( 2 the Valuation Committee of the Board on a quarterly basis reviews the preliminary valuation of the Advisor’s Valuation Committee and that of the independent valuation firms and makes the fair value determination, in good faith, based on the valuation recommendations of the Advisor’s Valuation Committee and the independent valuation firms; and ( 3 at each quarterly Board meeting, the Board considers the valuations recommended by the Advisor’s Valuation Committee and the independent valuation firms that were previously submitted to the Valuation Committee of the Board and ratifies the fair value determinations made by the Valuation Committee of the Board.

Note 4 - Investment Management

Note 4 - Investment Management Fee	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 4. The Company has entered into an investment management agreement (the “Investment Management Agreement”) with FCM pursuant to which the Company will pay FCM a fee for providing investment management services consisting of two The base management fee will be calculated at an annual rate of 2.00% of our gross assets. For services rendered under the Investment Management Agreement, the base management fee will be payable quarterly in arrears. The base management fee will be calculated based on the average of ( 1 2 The incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement, as of the termination date), commencing on April 15, 2011, December 31, 2022, twelve three March 31, 2024, Effective September 30, 2023, 1 October 1, 2023, December 31, 2024, 2 September 30, 2023. 2 may ten Effective March 31, 2024, March 31, 2024. may ten

Note 5 - Debt

Note 5 - Debt	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 5. The Company currently has no not

Note 6 - Fair value

Note 6 - Fair value	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 6. Securities traded on stock exchanges, or quoted by NASDAQ, are valued according to the NASDAQ Stock Market, Inc. (“NASDAQ”) official closing price, if applicable, or at their last reported sale price as of the close of trading on the New York Stock Exchange (“NYSE”) (normally 4:00 not Securities traded in the over-the-counter market, but not not Securities traded both in the over-the-counter market and on a stock exchange are valued according to the broadest and most representative market. Securities and other assets that do not 2a 5. In pricing illiquid, privately placed securities, FCM, as the valuation designee, is responsible for ( 1 2 FCM and the Board receive information and recommendations from an independent valuation firm. The values assigned to these investments are based on available information and do not APPROACHES TO DETERMINING FAIR VALUE. 1940 The main approaches to measuring fair value utilized are the market approach, the income approach, and the asset-based approach. The choice of which approach to use in a particular situation depends on the specific facts and circumstances associated with the company, as well as the purpose for which the valuation analysis is being conducted. Firsthand and the independent valuation firm rely primarily on the market approach. We also considered the income and asset-based approaches in our analysis because certain of the portfolio companies do not - Market Approach (M): The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. For example, the market approach often uses market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range each appropriate multiple falls requires the use of judgment in considering factors specific to the measurement (qualitative and quantitative). - Income Approach (I): The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) to a single present value amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. Those valuation techniques include present value techniques; option-pricing models, such as the Black-Scholes-Merton formula (a closed-form model) and a binomial model (a lattice model), which incorporate present value techniques; and the multi-period excess earnings method, which is used to measure the fair value of certain assets. - Asset-Based Approach (A): The asset-based approach examines the value of a company’s assets net of its liabilities to derive a value for the equity holders. FAIR VALUE MEASUREMENT. 1 3 The guidance establishes three Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the date of measurement. Level 2 Observable inputs other than quoted prices included in Level 1 may Level 3 Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not 3. The inputs used to measure fair value may The inputs or methodology used for valuing securities are not March 31, 2024: ASSETS LEVEL 1 LEVEL 2 OTHER LEVEL 3 SIGNIFICANT Common Stocks Advanced Materials $ — $ — $ 294,836 Equipment Leasing — — 9 Semiconductor Equipment — — 1,010,659 Total Common Stocks — — 1,305,504 Preferred Stocks Equipment Leasing — — 63,148 Total Preferred Stocks — — 63,148 Asset Derivatives* Equity Contracts — — — Total Asset Derivatives — — — Convertible and Non-Convertible Notes Aerospace — — 3,158,389 Medical Devices — — 125,462 Total Convertible and Non-Convertible Notes — — 3,283,851 Mutual Funds 43,239 — — Total $ 43,239 $ — $ 4,652,503 * Asset derivatives include warrants. At the end of each calendar quarter, management evaluates the Level 2 3 not third 1 2 Following is a reconciliation of Level 3 INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) BALANCE AS OF NET NET SALES/ NET REALIZED NET UNREALIZED (1) TRANSFERS BALANCE AS OF Common Stocks Advanced Materials $ 299,932 $ — $ — $ — $ (5,096 ) $ — $ 294,836 Equipment Leasing 55 — — — (46 ) — 9 Semiconductor Equipment — — — — (2,851,746 ) 3,862,405 1,010,659 Total Common Stocks 299,987 — — — (2,856,888 ) 3,862,405 1,305,504 Preferred Stocks Equipment Leasing 110,172 — — — (47,204 ) — 63,148 Total Preferred Stocks 110,172 — — — (47,024 ) — 63,148 Convertible and Non-Convertible Notes Advanced Materials 100,000 — (100,000 ) — — — — Aerospace 4,200,000 — — — (1,041,611 ) — 3,158,389 Medical Devices 87,713 — — — 37,749 — 125,462 Total Convertible and Non-Convertible Notes 4,387,713 — (100,000 ) — (1,003,862 ) — 3,283,851 Total $ 4,797,872 $ — $ (100,000 ) $ — $ (3,907,774 ) $ 3,862,405 4,652,503 ( 1 The net change in unrealized appreciation (depreciation) from Level 3 March 31, 2024 The table below represents quantitative disclosure about significant unobservable inputs for Level 3 March 31, 2024: FAIR VALUE AT 3/31/2024 VALUATION TECHNIQUES(1) UNOBSERVABLE INPUTS RANGE (WEIGHTED AVG.)(1) Direct venture capital investments: Advanced Materials $ 0.3M Market Comparable Companies Revenue Multiple (2) 0.8x – 0.9x (0.9x) Option Pricing Model Years to Maturity (2) 5 years (5 years) Volatility (2) 50.0% (50.0%) Risk-Free Rate (2) 4.21% (4.21%) Discount for Lack of 22.9% (22.9%) Marketability (3) Direct venture capital investments: Aerospace $ 3.2M Market Comparable Companies EBITDA Multiple (2) 1.9x (1.9x) Direct venture capital investments: Automotive $ 0.0M Liquidation Value Market Value of Invested Capital $0 ($0) Direct venture capital investments: Equipment Leasing $ 0.1M Cash Value Years to Maturity (2) 5 years (5 years) Option Pricing Model Volatility (2) 50.0% (50.0%) Risk-Free Rate (2) 4.21% (4.21%) Direct venture capital investments: Medical Devices $ 0.1M Market Comparable Companies Revenue Multiple (2) 1.8x – 1.9x (1.9x) Market Comparable Transactions Risk-Free Rate (2) 4.40% (4.40%) Going Concern Probability (2) 10% (10%) Direct venture capital investments: Semiconductor Equipment $ 1.0M Public Market Price Public Market Price Weighting 25% (25%) Private Bid Price ( 1 Weighted average is calculated by weighting the significant unobservable input by the relative fair value of each investment in the category ( 2 An increase in the input would result in an increase in the security s valuation; a decrease in the input would result in a decrease in the security s valuation. ( 3 An increase in the input would result in a decrease in the security s valuation; a decrease in the input would result in an increase in the security s valuation. Changes in any of our unobservable inputs, individually, may Due to the inherent uncertainty of determining the fair value of investments that do not may may may may In addition, changes in the market environment and other events that may may

Note 7 - Federal Income Taxes

Note 7 - Federal Income Taxes	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 7. Beginning in 2018, no no December 31, 2018, June 30, 2018, The reorganization described in Note 1 not, The following information is based upon the U.S. federal income tax cost of portfolio investments as of March 31, 2024. FEDERAL INCOME Gross unrealized appreciation — Gross unrealized depreciation $ (129,141,664 ) Net unrealized depreciation $ (129,141,664 ) Federal income tax cost, Investments $ 133,837,406 The Company did not The Company’s income tax provision consists of the following as of December 31, 2023: Deferred tax (expense)/benefit Federal $ — State — Total deferred tax (expense)/benefit $ — Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Such temporary differences are principally: (i) taxes on unrealized gains/(losses), which are attributable to the temporary difference between fair market value and tax basis, and (ii) the net tax benefit of accumulated net operating losses and capital loss carryforwards. Deferred tax assets and liabilities are measured using effective tax rates expected to apply to taxable income in the years such temporary differences are realized or otherwise settled. Components of the Company’s deferred tax assets and liabilities as of December 31, 2023 AMOUNT Deferred tax assets: Net operating loss carryforward $ 3,465,923 Capital loss carryforward 9,161,034 Net unrealized losses (gains) on investment securities 35,040,442 Total deferred tax assets, net 47,667,399 Valuation allowance (47,667,399 ) Net $ — For the year ended December 31, 2023, The effective tax rate and statutory federal income tax rate for the three March 31, 2024 2023 THREE MONTHS ENDED THREE MONTHS ENDED Effective tax rate 0% 0% Statutory federal income tax rate 21% 21% The variance in the effective tax rate and statutory federal income tax rate for the three March 31, 2024, March 31, 2024, To the extent the Company has a deferred tax asset or if a portion of the deferred tax liability is offset by a tax asset resulting from net operating losses, consideration is given to whether or not 740, 740 not not may not not From time to time, and as new information becomes available, the Company will modify its forecasts, estimates or assumptions regarding its deferred tax liability or asset. Modifications of the Company’s estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance, changes in generally accepted accounting principles or related guidance or interpretations thereof, limitations imposed on net operating losses (if any), and changes in applicable tax law could result in increases or decreases in the Company’s NAV, which could be material. Such changes could have a material impact on the Company’s NAV and results of operations with respect to the Company’s shareholders in the period it is recorded, even though the shareholders at such time might not The Company’s policy is to classify interest and penalties associated with underpayment of federal and state income taxes, if any, as income tax expense on its Statement of Operations. As of December 31, 2023, not The Company files income tax returns in the U.S. federal jurisdiction and California. The Company has reviewed all major jurisdictions and concluded that there is no not 12 As of December 31, 2023, may As of December 31, 2023, may EXPIRATION DATE AMOUNT 12/31/24 $ 14,230,073 12/31/25 7,516,642 12/31/27 3,129,665 12/31/28 7,864,982 Total $ 32,741,364

Note 8 - Investment Transaction

Note 8 - Investment Transactions	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investment [Text Block]	NOTE 8. Investment transactions (excluding short-term investments) were as follows for the quarter ended March 31, 2024. PURCHASES AND SALES Purchase of investment securities $ — Proceeds from sales and maturities of investment securities $ (100,000 )

Note 9 - Share Buybacks

Note 9 - Share Buybacks	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Treasury Stock [Text Block]	NOTE 9. SHARE BUYBACKS. April 26, 2016 10b 18 1934, September 2016 On November 10, 2017 10b 18 December 31, 2017, December 31, 2017. On August 31, 2018 March 31, 2019. October 24, 2018. December 31, 2018, TENDER OFFERS. December 22, 2014, December 31, 2014 ( $23.2702 January 22, 2015 12:00 On December 16, 2019, not not February 14, 2020, March 31, 2020,

Note 10 - Investments in Affili

Note 10 - Investments in Affiliates and Controlled Investments	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	NOTE 10. Under the 1940 5% 25% 1940 25% December 31, 2023, March 31, 2024, AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE 3/31/2024 SHARES HELD Equipment Leasing EQX Capital, Inc. Common Stock* $ 55 $ — $ — $ — $ — $ (46 ) $ 9 100,000 EQX Capital, Inc. Series A Preferred Stock* 110,172 — — — — (47,024 ) 63,148 1,950,000 Total Equipment Leasing $ 110,227 $ — $ — $ (47,070 ) $ 63,157 Aerospace Hera Systems, Inc. Convertible Note* 3,431,683 — — — — (851,066 ) 2,580,617 5,359,791 Hera Systems, Inc. Convertible Note* 768,317 — 30,000 — — (190,545 ) 577,772 1,200,000 Hera Systems, Inc. Series A Preferred* — — — — — — — 3,642,324 Hera Systems, Inc. Series B Preferred* — — — — — — — 7,039,203 Hera Systems, Inc. Series B Warrants* — — — — — — — 12,250,000 Hera Systems, Inc. Series B Warrants* — — — — — — — 6,214,922 Hera Systems, Inc. Series B Warrants* — — — — — — — 5,250,000 Hera Systems, Inc. Series B Warrants* — — — — — — — 700,000 Hera Systems, Inc. Series C Preferred* — — — — — — — 2,650,000 Total Aerospace $ 4,200,000 $ 30,000 $ — $ (1,041,611 ) $ 3,158,389 Medical Devices AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note* $ 34,570 $ — $ — $ — $ — $ 14,878 $ 49,448 10,961,129 IntraOp Medical Corp. Convertible Note* 4,100 — — — — 1,764 5,864 1,300,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 678 2,255 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 678 2,255 500,000 IntraOp Medical Corp. Convertible Note* 9,461 — — — — 4,073 13,534 3,000,000 IntraOp Medical Corp. Convertible Note* 3,154 — — — — 1,357 4,511 1,000,000 IntraOp Medical Corp. Convertible Note* 1,261 — — — — 543 1,804 400,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 2,365 — — — — 1,018 3,383 750,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 3,154 — — — — 1,357 4,511 1,000,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note* $ 3,154 $ — $ — $ — $ — $ 1,357 $ 4,511 1,000,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 631 — — — — 271 902 200,000 IntraOp Medical Corp. Convertible Note* 2,208 — — — — 950 3,158 700,000 IntraOp Medical Corp. Convertible Note* 473 — — — — 204 677 150,000 IntraOp Medical Corp. Convertible Note* 1,104 — — — — 475 1,579 350,000 IntraOp Medical Corp. Series C Preferred* — — — — — — — 26,856,187 IntraOp Medical Corp. Term Note* 6,308 — — — — 2,714 9,022 2,000,000 Total Medical Devices $ 87,713 $ — $ — $ 37,749 $ 125,462 Semiconductor Equipment Revasum, Inc. CDI*(1) 3,862,405 — — — — (2,851,746 ) 1,010,659 39,774,889 Total Semiconductor Equipment $ 3,862,405 $ — $ — $ (2,851,746 ) $ 1,010,659 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Advanced Materials UCT Coatings, Inc. Common Stock 299,932 — — — — (5,096 ) 294,836 1,500,000 Total Advanced Materials $ 299,932 $ — $ — $ (5,096 ) $ 294,836 Automotive Wrightspeed, Inc. Common Stock* — — — — — — — 69,102 Wrightspeed, Inc. Convertible Note* — — — — — — — 200,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 100,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 125,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 165,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 135,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note* $ — $ — $ — $ — $ — $ — $ — 700,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 65,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 185,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 300,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 400,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 2,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,400,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,200,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,050,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 400,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 375,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 900,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 750,000 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note* $ — $ — $ — $ — $ — $ — $ — 4,929,015 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 40,000 Wrightspeed, Inc. Series AA Preferred* — — — — — — — 60,733,693 Total Automotive $ — $ — $ — $ — $ — Total Affiliates and Controlled Investments $ 8,560,277 $ 30,000 $ — $ (3,907,774 ) $ 4,652,503 Total Affiliates 299,932 — — (5,096 ) 294,836 Total Controlled Investments $ 8,260,345 $ 30,000 $ — $ (3,902,678 ) $ 4,357,667 * Controlled Investments. ( 1 CDI: CHESS Depositary Interests As of March 31, 2024, March 31, 2024, may not

Note 11 - Market Disruption and

Note 11 - Market Disruption and Geopolitical Risks	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Unusual or Infrequent Items, or Both, Disclosure [Text Block]	NOTE 11. Certain local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, or other events could have a significant impact on a security or instrument. Since 2020, 19 February 2022 March 2022 19 not

Note 12 - Subsequent Events

Note 12 - Subsequent Events	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 12. Management has evaluated the impact of all subsequent events on the Company through the date the financial statements were issued and Management has evaluated the impact of all subsequent events on the Company through the date the financial statements were issued and determined that there were no

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	ITEM 5 OTHER INFORMATION.
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	BASIS OF PRESENTATION. 10 946, Financial Services Investment Companies 946” 6, 10 12 X. Under the 1940 946, 6 X, December 31, 2018, no
Use of Estimates, Policy [Policy Text Block]	USE OF ESTIMATES.
Investment, Policy [Policy Text Block]	PORTFOLIO INVESTMENT VALUATIONS. 1940 2 41 1940 March 31, 2024, may 6
Cash and Cash Equivalents, Policy [Policy Text Block]	CASH AND CASH EQUIVALENTS. three
Restricted Investments [Policy Text Block]	RESTRICTED SECURITIES. March 31. 2024, December 31, 2023,
Revenue [Policy Text Block]	INCOME RECOGNITION.
Share Valuation [Policy Text Block]	SHARE VALUATION.
Gain (Loss) on Investments [Policy Text Block]	REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS.
Income Tax, Policy [Policy Text Block]	INCOME TAXES.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	FOREIGN CURRENCY TRANSLATION. not may
Securities Transactions [Policy Text Block]	SECURITIES TRANSACTIONS.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	CONCENTRATION OF CREDIT RISK. may
Derivatives, Policy [Policy Text Block]	OPTIONS. may may may Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option.
Compensation Related Costs, Policy [Policy Text Block]	DEFERRED COMPENSATION. December 26, 2022, March 31, 2024, January 1, 2025 The average monthly volume of the Company’s derivatives during the three March 31, 2024 PURCHASED OPTIONS WARRANTS (NOTIONAL WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — — —

Consolidated Financial Highli_2

Consolidated Financial Highlights (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investment Company, Financial Highlights [Table Text Block]	FOR THE THREE FOR THE FOR THE FOR THE FOR THE FOR THE Net asset value at beginning of period $ 0.18 $ 4.44 $ 13.75 $ 14.82 $ 17.70 $ 26.69 Income from investment operations: Net investment income (loss), before deferred taxes 0.41 0.16 (1.81 ) 0.44 (1) 0.09 (1) 0.90 (1) Deferred tax benefit — — — — — (0.08 ) Net investment gain (losses) 0.41 0.16 (1.81 ) 0.44 0.09 0.82 Net realized and unrealized gains (losses) on investments, before deferred taxes (0.57 ) (4.42 ) (7.50 ) (1.51 ) (2.30 ) (12.15 ) Deferred tax expense — — — — (1.13 ) 2.34 Net realized and unrealized gains (losses) on investments, after deferred taxes (0.57 ) (4.42 ) (7.50 ) (1.51 ) (3.43 ) (9.81 ) Total from investment operations (0.16 ) (4.26 ) (9.31 ) (1.07 ) (3.34 ) (8.99 ) Distributions from: Realized capital gains — — — — — — Anti-dilutive effect from capital share transactions — — — — 0.46 — Net asset value at end of period $ 0.02 $ 0.18 $ 4.44 $ 13.75 $ 14.82 $ 17.70 Market value at end of period $ 0.26 $ 0.30 $ 0.95 $ 4.01 $ 4.47 $ 6.43 Total Return Based on Net Asset Value (88.89 )% (A) (95.95 )% (67.71 )% (7.22 )% (16.27 )% (33.68 )% Based on Market Value (13.33 )% (A) (68.42 )% (76.31 )% (10.29 )% (30.48 )% (42.59 )% Net assets at end of period (millions) $ 0.2 $ 1.3 $ 30.6 $ 94.8 $ 102.1 $ 127.1 FOR THE THREE MONTHS ENDED FOR THE FOR THE FOR THE FOR THE FOR THE MARCH 31, YEAR ENDED YEAR ENDED YEAR ENDED YEAR ENDED YEAR ENDED 2024 DECEMBER 31, DECEMBER 31, DECEMBER 31, DECEMBER 31, DECEMBER 31, (Unaudited) 2023 2022 2021 2020 2019 Ratio of total expenses to average net assets: Before tax (benefit)/expense (1567.59 )% (B) (7.21 )% 4.11 % 3.12 % 3.10 % (2.84 )% (2) Deferred tax (benefit)/expense (3)(4) — — — — 8.02 % (5) (9.91 )% Total expenses (1567.59 )% (B) (7.21 )% 4.11 % 3.12 % 11.12 % (12.75 )% (2) Total expenses, excluding incentive fees and deferred tax expense (1567.59 )% (B) (7.21 )% 4.11 % 3.12 % 3.10 % 2.80 % Total expenses, excluding incentive fees, deferred tax expense and fee waiver 140.95 % (B) 11.91 % 4.11 % 3.12 % 3.10 % 2.80 % Ratio of net investment income (loss) to average net assets: Before tax benefit 1585.64 % (B) 8.13 % (20.96 )% 2.94 % 0.64 % 3.93 % (2) Deferred tax benefit (4)(6) — — — — — (0.33 )% Net investment income (loss) 1585.64 % (B) 8.13 % (20.96 )% 2.94 % 0.64 % 3.60 % Net investment income before fee waiver (122.90 )% (B) (10.99 )% (20.96 )% 2.94 % 0.64 % 3.60 % Portfolio turnover rate 0 % (A)(C) 1 % 15 % 16 % 13 % 18 %

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Summary Investment Holdings [Table Text Block]	PORTFOLIO COMPANY (% OF NET ASSETS) Interest SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT Maturity Rate ACQUISITION DATE VALUE ($) COST BASIS VALUE EQX CAPITAL, INC. ( 37.6 Equipment Leasing Common Stock *(1)(2)(4) 6/10/2016 100,000 $ 20,000 $ 9 Preferred Stock - Series A *(1)(2)(4) 6/10/2016 - 11/7/2016 1,950,000 1,950,000 63,148 63,157 HERA SYSTEMS, INC. ( 1880.9 Aerospace Convertible Note (1)(2)(4)(6) 12/31/2024 10% 12/29/2022 5,359,791 5,359,791 2,580,617 Convertible Note (1)(2)(4) 12/31/2024 10% 12/29/2022 1,200,000 1,200,000 577,772 Preferred Stock - Series A *(1)(2)(4) 9/18/2015 3,642,324 2,000,000 0 Preferred Stock - Series B *(1)(2)(4) 8/7/2017 - 2/1/2019 7,039,203 6,587,102 0 Preferred Stock - Series C *(1)(2)(4) 8/7/2019 - 2/12/2020 2,650,000 2,650,000 0 Preferred Stock Warrants - Series B *(1)(2)(4) 7/9/2018 - 9/4/2018 12,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 2/1/2019 5,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 8/7/2017 6,214,922 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 9/28/2017 700,000 0 0 3,158,389 INTRAOP MEDICAL CORP. ( 74.7 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/11/2019 500,000 500,000 2,255 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/22/2021 1,000,000 1,000,000 4,511 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/29/2019 500,000 500,000 2,255 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT Maturity Interest Rate ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/6/2021 500,000 $ 500,000 $ 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/12/2021 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/29/2021 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 12/31/2018 10,961,129 10,961,129 49,448 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/27/2020 1,000,000 1,000,000 4,511 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/28/2022 200,000 200,000 902 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/252020 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/30/2022 150,000 150,000 677 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/20/2021 1,000,000 1,000,000 4,511 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/6/2022 350,000 350,000 1,579 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/8/2020 400,000 400,000 1,804 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2021 500,000 500,000 2,256 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2022 700,000 $ 700,000 $ 3,158 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/12/2019 1,300,000 1,300,000 5,864 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/16/2021 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/31/2020 500,000 500,000 2,256 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 8/28/2020 750,000 750,000 3,383 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 9/22/2021 500,000 500,000 2,256 Preferred Stock - Series C *(1)(2)(4) 7/12/2013 26,856,187 26,299,939 0 Term Note (1)(2)(4)(6) 12/31/2024 8% 2/10/2017 2,000,000 2,000,000 9,022 Term Note (1)(2)(4)(6) 12/31/2024 8% 2/28/2014 3,000,000 3,000,000 13,534 125,462 LYNCEAN TECHNOLOGIES, INC. ( 0.0 Semiconductor Equipment Preferred Stock - Series B *(1)(4) 7/3/2018 869,792 1,000,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE REVASUM, INC. ( 601.9 Semiconductor Equipment CDIs *(2)(4) 11/14/2016 - 10/3/2022 39,774,889 $ 9,268,218 $ 1,010,659 UCT COATINGS, INC. ( 175.6 Advanced Materials Common Stock *(1)(3)(4) 4/18/2011 1,500,000 662,235 294,836 WRIGHTSPEED, INC. ( 0.0 Automotive Common Stock *(1)(2)(4) 6/7/2019 69,102 7,460,851 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 1/10/2023 100,000 100,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/23/2020 1,050,000 1,050,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/20/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/21/2022 135,000 135,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/5/2021 700,000 700,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/11/2020 400,000 400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/14/2022 165,000 165,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/23/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/24/2020 375,000 375,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/11/2020 400,000 $ 400,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/23/2020 2,000,000 2,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/28/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/9/2022 125,000 125,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2021 1,400,000 1,400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2022 200,000 200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 3/11/2022 185,000 185,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/12/2021 1,200,000 1,200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/14/2022 65,000 65,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/10/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5//18/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/26/2022 250,000 250,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/10/2022 250,000 $ 250,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/22/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/28/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/7/2019 4,929,015 4,929,015 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/13/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/26/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/28/ 2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2020 750,000 750,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/19/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/10/2022 900,000 900,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/22/2021 300,000 300,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 18% 7/25/2023 40,000 $ 40,000 $ 0 Preferred Stock - Series AA *(1)(2)(4) 6/7/2019 - 7/20/2020 60,733,693 17,355,887 0 0 INVESTMENT COMPANY ( 25.7 Fidelity Investments Money Market Treasury Portfolio - Class I (5) Various 43,239 43,239 43,239 TOTAL INVESTMENTS (Cost $ 133,837,406 2796.4 $ 4,695,742 LIABILITIES IN EXCESS OF OTHER ASSETS — ( 2696.4 (4,527,822 ) NET ASSETS — 100.0 $ 167,920 PORTFOLIO COMPANY (% OF NET ASSETS) INTEREST SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE EQX CAPITAL, INC. ( 8.8 Common Stock *(1)(2)(4) June 10, 2016 100,000 $ 20,000 $ 55 Equipment Leasing Preferred Stock - Series A *(1)(2)(4) June 10, 2016 - 11/72016 1,950,000 1,950,000 110,172 110,227 HERA SYSTEMS, INC. ( 333.2 Convertible Note (1)(2)(4) 12/31/2024 10% 12/29/2022 1,200,000 1,200,000 768,317 Convertible Note (1)(2)(4)(6) 12/31/2024 10% 12/29/2022 5,359,791 5,359,791 3,431,683 Preferred Stock - Series A *(1)(2)(4) 9/18/2015 3,642,324 2,000,000 0 Preferred Stock - Series B *(1)(2)(4) 8/7/2017 - 2/1/2019 7,039,203 6,587,102 0 Preferred Stock - Series C *(1)(2)(4) 8/7/2019 - 2/12/2020 2,650,000 2,650,000 0 Preferred Stock Warrants - Series B *(1)(2)(4) 7/9/2018 - 9/4/2018 12,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 2/1/2019 5,250,000 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 8/7/2017 6,214,922 0 0 Preferred Stock Warrants - Series B *(1)(2)(4) 9/28/2017 700,000 0 0 4,200,000 INTRAOP MEDICAL CORP. ( 7.0 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 12/31/2018 10,961,129 10,961,129 34,570 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/12/2019 1,300,000 1,300,000 4,100 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/11/2019 500,000 500,000 1,577 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/29/2019 500,000 $ 500,000 $ 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/27/2020 1,000,000 1,000,000 3,154 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/25/2020 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 5/8/2020 400,000 400,000 1,261 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/31/2020 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/28/2020 750,000 750,000 2,365 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/20/2021 1,000,000 1,000,000 3,154 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 7/16/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 9/22/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/6/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 10/22/2021 1,000,000 1,000,000 3,154 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE INTRAOP MEDICAL CORP. (continued) Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/12//2021 500,000 $ 500,000 $ 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 11/29/2021 500,000 500,000 1,577 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 2/28/2022 200,000 200,000 631 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 3/30/2022 150,000 150,000 473 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 4/6/2022 350,000 350,000 1,104 Convertible Note (1)(2)(4)(6) 12/31/2024 15% 6/10/2022 700,000 700,000 2,208 Preferred Stock - Series C *(1)(2)(4) 7/12/2013 26,856,187 26,299,938 0 Term Note Matures (1)(2)(4)(6) 12/31/2024 8% 2/28/2014 3,000,000 3,000,000 9,461 Term Note Matures (1)(2)(4)(6) 12/31/2024 8% 2/10/2017 2,000,000 2,000,000 6,308 87,713 KYMA, INC. ( 7.9 Advanced Materials Convertible Note (1)(4) 3/30/2024 10% 3/1//2019 100,000 100,000 100,000 LYNCEAN TECHNOLOGIES, INC. ( 0.0 Preferred Stock - Series B *(1)(4) 7/3/2018 869,792 1,000,000 0 Semiconductor Equipment PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE REVASUM, INC. ( 306.5 CDIs *(2) 11/14/2016 - 10/3/2022 39,774,889 $ 9,268,219 $ 3,862,405 Semiconductor Equipment UCT COATINGS, INC. ( 23.8 Common Stock *(1)(3)(4) 4/18/2011 1,500,000 662,235 299,932 Advanced Materials WRIGHTSPEED, INC. ( 0.0 Common Stock *(1)(2)(4) 4/11/2013 - 5/6//2019 69,102 7,460,851 0 Automotive Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/7/2019 4,929,015 4,929,015 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2020 750,000 750,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/10/2020 900,000 900,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/13/2020 1,050,000 1,050,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/11/2020 400,000 400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/24/2020 375,000 375,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/11/2020 400,000 400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/23/2020 2,000,000 2,000,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2021 1,400,000 1,400,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/12/2021 1,200,000 1,200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/18/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/22/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/26/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/19/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 9/22/2021 300,000 300,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/5/2021 700,000 $ 700,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/20/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/23/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/28/2021 1,000,000 1,000,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 2/23/2022 200,000 200,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 3/11/2022 185,000 185,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 4/14/2022 65,000 65,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/10/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 5/26/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/10/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 6/28/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/13/2022 250,000 250,000 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT MATURITY INTEREST RATE ACQUISITION DATE VALUE ($) COST BASIS VALUE WRIGHTSPEED, INC. (continued) Convertible Note (1)(2)(4)(6) 6/30/2024 12% 7/28/2022 250,000 $ 250,000 $ 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 8/12/2022 250,000 250,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 10/21/2022 135,000 135,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 11/14/2022 165,000 165,000 0 Convertible Note (1)(2)(4)(6) 6/30/2024 12% 12/9/2022 125,000 125,000 0 Preferred Stock - Series AA *(1)(2)(4) 6/7/2019 - 7/20/2020 60,733,693 17,355,887 0 Preferred Stock Warrants - Series AA *(1)(2)(4) 6/7/2019 609,756 0 0 0 PORTFOLIO COMPANY (% OF NET ASSETS) SHARES/PAR AND INDUSTRY TYPE OF INVESTMENT ACQUISITION DATE VALUE ($) COST BASIS VALUE INVESTMENT COMPANY (5.8 Fidelity Investments Money Market Treasury Portfolio - Class I (5) Various 73,502 $ 73,502 $ 73,502 TOTAL INVESTMENTS (Cost $ 133,967,669 693.0 $ 8,733,779 LIABILITIES IN EXCESS OF OTHER ASSETS ( 593.0 (7,473,408 ) NET ASSETS 100.0 $ 1,260,371

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Derivative Instruments [Table Text Block]	PURCHASED OPTIONS WARRANTS (NOTIONAL WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — — —

Note 6 - Fair value (Tables)

Note 6 - Fair value (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	ASSETS LEVEL 1 LEVEL 2 OTHER LEVEL 3 SIGNIFICANT Common Stocks Advanced Materials $ — $ — $ 294,836 Equipment Leasing — — 9 Semiconductor Equipment — — 1,010,659 Total Common Stocks — — 1,305,504 Preferred Stocks Equipment Leasing — — 63,148 Total Preferred Stocks — — 63,148 Asset Derivatives* Equity Contracts — — — Total Asset Derivatives — — — Convertible and Non-Convertible Notes Aerospace — — 3,158,389 Medical Devices — — 125,462 Total Convertible and Non-Convertible Notes — — 3,283,851 Mutual Funds 43,239 — — Total $ 43,239 $ — $ 4,652,503
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) BALANCE AS OF NET NET SALES/ NET REALIZED NET UNREALIZED (1) TRANSFERS BALANCE AS OF Common Stocks Advanced Materials $ 299,932 $ — $ — $ — $ (5,096 ) $ — $ 294,836 Equipment Leasing 55 — — — (46 ) — 9 Semiconductor Equipment — — — — (2,851,746 ) 3,862,405 1,010,659 Total Common Stocks 299,987 — — — (2,856,888 ) 3,862,405 1,305,504 Preferred Stocks Equipment Leasing 110,172 — — — (47,204 ) — 63,148 Total Preferred Stocks 110,172 — — — (47,024 ) — 63,148 Convertible and Non-Convertible Notes Advanced Materials 100,000 — (100,000 ) — — — — Aerospace 4,200,000 — — — (1,041,611 ) — 3,158,389 Medical Devices 87,713 — — — 37,749 — 125,462 Total Convertible and Non-Convertible Notes 4,387,713 — (100,000 ) — (1,003,862 ) — 3,283,851 Total $ 4,797,872 $ — $ (100,000 ) $ — $ (3,907,774 ) $ 3,862,405 4,652,503
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	FAIR VALUE AT 3/31/2024 VALUATION TECHNIQUES(1) UNOBSERVABLE INPUTS RANGE (WEIGHTED AVG.)(1) Direct venture capital investments: Advanced Materials $ 0.3M Market Comparable Companies Revenue Multiple (2) 0.8x – 0.9x (0.9x) Option Pricing Model Years to Maturity (2) 5 years (5 years) Volatility (2) 50.0% (50.0%) Risk-Free Rate (2) 4.21% (4.21%) Discount for Lack of 22.9% (22.9%) Marketability (3) Direct venture capital investments: Aerospace $ 3.2M Market Comparable Companies EBITDA Multiple (2) 1.9x (1.9x) Direct venture capital investments: Automotive $ 0.0M Liquidation Value Market Value of Invested Capital $0 ($0) Direct venture capital investments: Equipment Leasing $ 0.1M Cash Value Years to Maturity (2) 5 years (5 years) Option Pricing Model Volatility (2) 50.0% (50.0%) Risk-Free Rate (2) 4.21% (4.21%) Direct venture capital investments: Medical Devices $ 0.1M Market Comparable Companies Revenue Multiple (2) 1.8x – 1.9x (1.9x) Market Comparable Transactions Risk-Free Rate (2) 4.40% (4.40%) Going Concern Probability (2) 10% (10%) Direct venture capital investments: Semiconductor Equipment $ 1.0M Public Market Price Public Market Price Weighting 25% (25%) Private Bid Price

Note 7 - Federal Income Taxes (

Note 7 - Federal Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Federal Income Tax Note [Table Text Block]	FEDERAL INCOME Gross unrealized appreciation — Gross unrealized depreciation $ (129,141,664 ) Net unrealized depreciation $ (129,141,664 ) Federal income tax cost, Investments $ 133,837,406
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Deferred tax (expense)/benefit Federal $ — State — Total deferred tax (expense)/benefit $ —
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	AMOUNT Deferred tax assets: Net operating loss carryforward $ 3,465,923 Capital loss carryforward 9,161,034 Net unrealized losses (gains) on investment securities 35,040,442 Total deferred tax assets, net 47,667,399 Valuation allowance (47,667,399 ) Net $ —
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	THREE MONTHS ENDED THREE MONTHS ENDED Effective tax rate 0% 0% Statutory federal income tax rate 21% 21%
Summary of Operating Loss Carryforwards [Table Text Block]	EXPIRATION DATE AMOUNT 12/31/24 $ 14,230,073 12/31/25 7,516,642 12/31/27 3,129,665 12/31/28 7,864,982 Total $ 32,741,364

Note 8 - Investment Transacti_2

Note 8 - Investment Transactions (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investment [Table Text Block]	PURCHASES AND SALES Purchase of investment securities $ — Proceeds from sales and maturities of investment securities $ (100,000 )

Note 10 - Investments in Affi_2

Note 10 - Investments in Affiliates and Controlled Investments (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investments in and Advances to Affiliates [Table Text Block]	AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE 3/31/2024 SHARES HELD Equipment Leasing EQX Capital, Inc. Common Stock* $ 55 $ — $ — $ — $ — $ (46 ) $ 9 100,000 EQX Capital, Inc. Series A Preferred Stock* 110,172 — — — — (47,024 ) 63,148 1,950,000 Total Equipment Leasing $ 110,227 $ — $ — $ (47,070 ) $ 63,157 Aerospace Hera Systems, Inc. Convertible Note* 3,431,683 — — — — (851,066 ) 2,580,617 5,359,791 Hera Systems, Inc. Convertible Note* 768,317 — 30,000 — — (190,545 ) 577,772 1,200,000 Hera Systems, Inc. Series A Preferred* — — — — — — — 3,642,324 Hera Systems, Inc. Series B Preferred* — — — — — — — 7,039,203 Hera Systems, Inc. Series B Warrants* — — — — — — — 12,250,000 Hera Systems, Inc. Series B Warrants* — — — — — — — 6,214,922 Hera Systems, Inc. Series B Warrants* — — — — — — — 5,250,000 Hera Systems, Inc. Series B Warrants* — — — — — — — 700,000 Hera Systems, Inc. Series C Preferred* — — — — — — — 2,650,000 Total Aerospace $ 4,200,000 $ 30,000 $ — $ (1,041,611 ) $ 3,158,389 Medical Devices AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note* $ 34,570 $ — $ — $ — $ — $ 14,878 $ 49,448 10,961,129 IntraOp Medical Corp. Convertible Note* 4,100 — — — — 1,764 5,864 1,300,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 678 2,255 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 678 2,255 500,000 IntraOp Medical Corp. Convertible Note* 9,461 — — — — 4,073 13,534 3,000,000 IntraOp Medical Corp. Convertible Note* 3,154 — — — — 1,357 4,511 1,000,000 IntraOp Medical Corp. Convertible Note* 1,261 — — — — 543 1,804 400,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 2,365 — — — — 1,018 3,383 750,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 3,154 — — — — 1,357 4,511 1,000,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note* $ 3,154 $ — $ — $ — $ — $ 1,357 $ 4,511 1,000,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 1,577 — — — — 679 2,256 500,000 IntraOp Medical Corp. Convertible Note* 631 — — — — 271 902 200,000 IntraOp Medical Corp. Convertible Note* 2,208 — — — — 950 3,158 700,000 IntraOp Medical Corp. Convertible Note* 473 — — — — 204 677 150,000 IntraOp Medical Corp. Convertible Note* 1,104 — — — — 475 1,579 350,000 IntraOp Medical Corp. Series C Preferred* — — — — — — — 26,856,187 IntraOp Medical Corp. Term Note* 6,308 — — — — 2,714 9,022 2,000,000 Total Medical Devices $ 87,713 $ — $ — $ 37,749 $ 125,462 Semiconductor Equipment Revasum, Inc. CDI*(1) 3,862,405 — — — — (2,851,746 ) 1,010,659 39,774,889 Total Semiconductor Equipment $ 3,862,405 $ — $ — $ (2,851,746 ) $ 1,010,659 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Advanced Materials UCT Coatings, Inc. Common Stock 299,932 — — — — (5,096 ) 294,836 1,500,000 Total Advanced Materials $ 299,932 $ — $ — $ (5,096 ) $ 294,836 Automotive Wrightspeed, Inc. Common Stock* — — — — — — — 69,102 Wrightspeed, Inc. Convertible Note* — — — — — — — 200,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 100,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 125,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 165,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 135,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note* $ — $ — $ — $ — $ — $ — $ — 700,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 65,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 185,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 300,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 400,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 2,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,400,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,200,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 250,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,050,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 400,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 375,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 900,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 750,000 AFFILIATE/ CONTROLLED INVESTMENTS* VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note* $ — $ — $ — $ — $ — $ — $ — 4,929,015 Wrightspeed, Inc. Convertible Note* — — — — — — — 1,000,000 Wrightspeed, Inc. Convertible Note* — — — — — — — 40,000 Wrightspeed, Inc. Series AA Preferred* — — — — — — — 60,733,693 Total Automotive $ — $ — $ — $ — $ — Total Affiliates and Controlled Investments $ 8,560,277 $ 30,000 $ — $ (3,907,774 ) $ 4,652,503 Total Affiliates 299,932 — — (5,096 ) 294,836 Total Controlled Investments $ 8,260,345 $ 30,000 $ — $ (3,902,678 ) $ 4,357,667

Consolidated Financial Highli_3

Consolidated Financial Highlights (Details Textual)	3 Months Ended		12 Months Ended
	Mar. 31, 2024		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investment Company, Incentive Fee to Average Net Assets							5.64%
Investment Company, Portfolio Turnover	0%	[1],[2]	1%	15%	16%	13%	18%
Maximum [Member]
Investment Company, Portfolio Turnover	1%
[1]Less than 1%[2]Not Annualized.

Consolidated Financial Highli_4

Consolidated Financial Highlights - Schedule of Financial Highlights (Details) - USD ($)		3 Months Ended		12 Months Ended
		Mar. 31, 2024		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Net asset value at beginning of period (in dollars per share)		$ 0.18		$ 4.44		$ 13.75		$ 14.82		$ 17.7		$ 26.69
Income from investment operations:
Net investment income (loss), before deferred taxes (in dollars per share)		0.41		0.16	[1]	(1.81)	[1]	0.44	[1]	0.09	[1]	0.9	[1]
Deferred tax benefit (in dollars per share)		0		0		0		0		0		(0.08)
Net investment gain (losses) (in dollars per share)		0.41		0.16		(1.81)		0.44		0.09		0.82
Net realized and unrealized gains (losses) on investments, before deferred taxes (in dollars per share)		(0.57)		(4.42)		(7.5)		(1.51)		(2.3)		(12.15)
Deferred tax expense (in dollars per share)		0		0		0		0		(1.13)		2.34
Net realized and unrealized gains (losses) on investments, after deferred taxes (in dollars per share)		(0.57)		(4.42)		(7.5)		(1.51)		(3.43)		(9.81)
Total from investment operations (in dollars per share)		(0.16)		(4.26)		(9.31)		(1.07)		(3.34)		(8.99)
Distributions from:
Realized capital gains (in dollars per share)		0		0		0		0		0		0
Anti-dilutive effect from capital share transactions (in dollars per share)		0		0		0		0		0.46		0
Net asset value at end of period (in dollars per share)		0.02		0.18		4.44		13.75		14.82		17.7
Market value at end of period (in dollars per share)		$ 0.26		$ 0.3		$ 0.95		$ 4.01		$ 4.47		$ 6.43
Total Return
Based on Net Asset Value		(88.89%)		(95.95%)		(67.71%)		(7.22%)		(16.27%)		(33.68%)
Based on Market Value		(13.33%)		(68.42%)		(76.31%)		(10.29%)		(30.48%)		(42.59%)
End of period		$ 167,920		$ 1,260,371		$ 30,609,591		$ 94,800,000		$ 102,100,000		$ 127,100,000
Before tax (benefit)/expense		1,567.59%	[2]	7.21%		(4.11%)		(3.12%)	[3]	(3.10%)	[3]	2.84%	[3]
Deferred tax (benefit)/expense(3)(4)	[4],[5]	0%	[2]	0%	[6]	0%	[6]	0%		(8.02%)		9.91%
Total expenses		(1567.59%)	[2]	(7.21%)		4.11%		3.12%	[3]	11.12%	[3]	(12.75%)	[3]
Total expenses, excluding incentive fees and deferred tax expense		(1567.59%)	[2]	(7.21%)		4.11%		3.12%		3.10%		2.80%
Total expenses, excluding incentive fees, deferred tax expense and fee waiver		140.95%	[2]	11.91%		4.11%		3.12%		3.10%		2.80%
Before tax benefit		1,585.64%	[2]	8.13%		(20.96%)		2.94%		0.64%		3.93%
Deferred tax benefit (4)(6)	[5],[7]	0%	[2]	0%		0%		0%		0%		(0.33%)
Net investment income (loss)		1,585.64%	[2]	8.13%		(20.96%)		2.94%		0.64%		3.60%
Net investment income before fee waiver		(122.90%)	[2]	(10.99%)		(20.96%)		2.94%		0.64%		3.60%
Portfolio turnover rate		0%	[8],[9]	1%		15%		16%		13%		18%
[1]Calculated using average shares outstanding.[2]Annualized.[3]Amount includes the incentive fee. For the year ended December 31, 2019, the ratio of the incentive fee to average net assets was (5.64)%.[4]Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses).[5]The deferred tax expense and tax benefit are based on average net assets.[6]As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense.[7]Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only.[8]Less than 1%[9]Not Annualized.

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Details Textual) - USD ($)		Mar. 31, 2024	Dec. 31, 2023
Investment Owned, Fair Value	[1]	$ 4,695,742	$ 8,733,779
Investment Owned, Net Assets, Percentage		2,796.40%	693%
Fair Value, Inputs, Level 3 [Member]
Investment Owned, Fair Value		$ 4,652,503
Restricted Securities [Member]
Investment Owned, Fair Value		$ 3,641,844	$ 4,797,872
Investment Owned, Net Assets, Percentage		2,168.80%	380.70%
Restricted Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investment Owned, Net Assets, Percentage		2,770.70%	380.70%
[1]Includes warrants whose primary risk exposure is equity contracts.

Consolidated Schedule of Inve_4

Consolidated Schedule of Investments - Schedule of Investments (Details) - USD ($)		3 Months Ended		12 Months Ended
		Mar. 31, 2024		Dec. 31, 2023		Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investment, cost		$ 133,837,406		$ 133,967,669
Investment, percent of net assets	[1]	4,695,742		8,733,779
Investment owned, cost		$ 133,837,406		$ 133,967,669
Investment, percent of net assets		2,796.40%		693%
LIABILITIES IN EXCESS OF OTHER ASSETS — (2696.4)%		$ (4,527,822)		$ (7,473,408)
NET ASSETS — 100.0%		167,920		1,260,371		$ 25,867,367	$ 30,609,591	$ 94,800,000	$ 102,100,000	$ 127,100,000
Equipment Leasing Sector [Member] | EQX Capital, Inc [Member]
Investment, percent of net assets		$ 63,157		$ 110,227	[2],[3],[4],[5]
Investment, percent of net assets				8.80%
Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Investment, shares/par value (in shares)	[2],[3],[5],[6]
Investment, cost	[2],[3],[5],[6]
Investment, percent of net assets	[2],[3]	125,462	[5],[6]	$ 87,713	[7],[8]
Investment owned, cost	[2],[3],[5],[6]
Investment, percent of net assets		74.70%		7%
Semiconductor Equipment Sector [Member] | Revasum, Inc [Member]
Investment, percent of net assets		$ 31,583.89
Investment, percent of net assets		601.90%		306.50%
Semiconductor Equipment Sector [Member] | Lyncean Technologies, Inc. [Member]
Investment, percent of net assets		$ 0
Investment, percent of net assets				0%
Automotive Sector [Member] | Wrightspeed Inc [Member]
Investment, percent of net assets		$ 0	[2],[3],[5],[6]	$ 0
Investment, percent of net assets		0%		0%
Investment Sector [Member] | Fidelity Investments [Member]
Investment, shares/par value (in shares)	[9]	43,239		73,502
Investment, cost	[9]	$ 43,239		$ 73,502
Investment, percent of net assets	[9]	43,239		73,502
Investment owned, cost	[9]	$ 43,239		$ 73,502
Investment, percent of net assets		25.70%		5.80%
Advanced Materials Sector [Member] | UCT Coatings, Inc. [Member]
Investment, percent of net assets		175.60%		23.80%
Advanced Materials Sector [Member] | Kyma, INC. [Member]
Investment, percent of net assets				7.90%
Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Investment, cost	[2],[3],[4],[6]
Investment, percent of net assets	[2],[3],[4],[5]			4,200,000
Investment owned, cost	[2],[3],[4],[6]
Investment, percent of net assets				333.20%
Common Stock [Member] | Equipment Leasing Sector [Member] | EQX Capital, Inc [Member]
Acquisition date		Jun. 10, 2016	[2],[3],[4],[5]	Jun. 10, 2016
Investment, shares/par value (in shares)		100,000	[2],[3],[4],[5]	100,000
Investment, cost		$ 20,000	[2],[3],[4],[5]	$ 20,000
Investment, percent of net assets		$ 9	[2],[3],[4],[5]	$ 55
Acquisition date		Jun. 10, 2016	[2],[3],[4],[5]	Jun. 10, 2016
Investment owned, cost		$ 20,000	[2],[3],[4],[5]	$ 20,000
Common Stock [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[4],[5]	Jun. 07, 2019
Investment, shares/par value (in shares)	[2],[3]	69,102	[4],[5]	69,102	[7]
Investment, cost	[2],[3]	$ 7,460,851	[4]	$ 7,460,851	[7]
Investment, percent of net assets	[2],[3]	$ 0	[4],[5],[6]	$ 0	[7]
Interest rate	[2],[3],[6],[7]			12%
Acquisition date	[2],[3],[4],[5]	Jun. 07, 2019
Investment owned, cost	[2],[3]	$ 7,460,851	[4]	$ 7,460,851	[7]
Interest rate	[2],[3],[6],[7]			12%
Common Stock [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member] | Minimum [Member]
Acquisition date	[2],[3],[7]			Apr. 11, 2013
Acquisition date	[2],[3],[7]			Apr. 11, 2013
Common Stock [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member] | Maximum [Member]
Acquisition date	[2],[3],[7]			May 06, 2019
Acquisition date	[2],[3],[7]			May 06, 2019
Common Stock [Member] | Advanced Materials Sector [Member] | UCT Coatings, Inc. [Member]
Acquisition date	[3],[10]	Apr. 18, 2011	[4],[5]	Apr. 18, 2011	[7]
Investment, shares/par value (in shares)	[3],[10]	1,500,000	[4],[5]	1,500,000	[7]
Investment, cost	[3],[10]	$ 662,235	[4],[5]	$ 662,235	[7]
Investment, percent of net assets	[3],[10]	$ 294,836	[4],[5]	$ 299,932	[7]
Acquisition date	[3],[10]	Apr. 18, 2011	[4],[5]	Apr. 18, 2011	[7]
Investment owned, cost	[3],[10]	$ 662,235	[4],[5]	$ 662,235	[7]
Convertible Debt 4 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[6]	Oct. 06, 2021	[5]	Oct. 29, 2019	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	500,000	[5]	500,000	[7]
Investment, cost	[2],[3],[6]	$ 500,000	[5]	$ 500,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 2,256	[5]	$ 1,577	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[2],[3],[6]	Oct. 06, 2021	[5]	Oct. 29, 2019	[7]
Investment owned, cost	[2],[3],[6]	$ 500,000	[5]	$ 500,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 4 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Oct. 21, 2022	[5],[6]	Oct. 13, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	135,000	[5],[6]	1,050,000	[7],[8]
Investment, cost	[2],[3]	$ 135,000	[5],[6]	$ 1,050,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Oct. 21, 2022	[5],[6]	Oct. 13, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 135,000	[5],[6]	$ 1,050,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 16 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[6]	Jun. 10, 2022	[5]	Nov. 11, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	700,000	[5]	500,000	[7]
Investment, cost	[2],[3],[6]	$ 700,000	[5]	$ 500,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 3,158	[5]	$ 1,577	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[2],[3],[6]	Jun. 10, 2022	[5]	Nov. 11, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 700,000	[5]	$ 500,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 16 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Mar. 11, 2022	[5]	Oct. 05, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	185,000	[5]	700,000	[7]
Investment, cost	[2],[3],[6]	$ 185,000	[5]	$ 700,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Mar. 11, 2022	[5]	Oct. 05, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 185,000	[5]	$ 700,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Chess Depositary Interests (CDIs) [Member] | Semiconductor Equipment Sector [Member] | Revasum, Inc [Member]
Investment, shares/par value (in shares)	[2]	39,774,889	[3],[4]	39,774,889
Investment, cost	[2]	$ 9,268,218	[3],[4]	$ 9,268,219
Investment, percent of net assets	[2]	1,010,659	[3],[4]	3,862,405
Investment owned, cost	[2]	$ 9,268,218	[3],[4]	$ 9,268,219
Chess Depositary Interests (CDIs) [Member] | Semiconductor Equipment Sector [Member] | Revasum, Inc [Member] | Minimum [Member]
Acquisition date	[2]	Nov. 14, 2016	[3],[4]	Nov. 14, 2016
Acquisition date	[2]	Nov. 14, 2016	[3],[4]	Nov. 14, 2016
Chess Depositary Interests (CDIs) [Member] | Semiconductor Equipment Sector [Member] | Revasum, Inc [Member] | Maximum [Member]
Acquisition date	[2]	Oct. 03, 2022	[3],[4]	Oct. 03, 2022
Acquisition date	[2]	Oct. 03, 2022	[3],[4]	Oct. 03, 2022
Convertible Debt 10 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Mar. 25, 2020	[5]	Apr. 20, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	500,000	[5]	1,000,000	[7],[8]
Investment, cost	[2],[3]	$ 500,000	[5]	$ 1,000,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 2,256	[5]	$ 3,154	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Mar. 25, 2020	[5]	Apr. 20, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 500,000	[5]	$ 1,000,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 10 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Dec. 11, 2020	[5]	Apr. 12, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	400,000	[5]	1,200,000	[7]
Investment, cost	[2],[3],[6]	$ 400,000	[5]	$ 1,200,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Dec. 11, 2020	[5]	Apr. 12, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 400,000	[5]	$ 1,200,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 22 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jun. 10, 2022	[5],[6]	Apr. 14, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	250,000	[5],[6]	65,000	[7],[8]
Investment, cost	[2],[3]	$ 250,000	[5],[6]	$ 65,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jun. 10, 2022	[5],[6]	Apr. 14, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 250,000	[5],[6]	$ 65,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 34 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[5],[6]	Jul. 25, 2023
Investment, shares/par value (in shares)	[2],[3],[5],[6]	40,000
Investment, cost	[2],[3],[5],[6]	$ 40,000
Investment, percent of net assets	[2],[3],[5],[6]	$ 0
Maturity date	[2],[3],[5],[6]	Dec. 31, 2024
Interest rate	[2],[3],[5],[6]	18%
Acquisition date	[2],[3],[5],[6]	Jul. 25, 2023
Investment owned, cost	[2],[3],[5],[6]	$ 40,000
Interest rate	[2],[3],[5],[6]	18%
Convertible Debt 9 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Feb. 28, 2022	[5],[6]	Jul. 28, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	200,000	[5],[6]	750,000	[7],[8]
Investment, cost	[2],[3]	$ 200,000	[5],[6]	$ 750,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 902	[5],[6]	$ 2,365	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Feb. 28, 2022	[5],[6]	Jul. 28, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 200,000	[5],[6]	$ 750,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 9 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Nov. 24, 2020	[5]	Feb. 23, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	375,000	[5]	1,400,000	[7]
Investment, cost	[2],[3],[6]	$ 375,000	[5]	$ 1,400,000	[7]
Investment, percent of net assets		$ 0		$ 0	[2],[3],[6],[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[5],[6]	12%
Acquisition date	[2],[3],[6]	Nov. 24, 2020	[5]	Feb. 23, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 375,000	[5]	$ 1,400,000	[7]
Interest rate	[2],[3],[5],[6]	12%
Convertible Debt 28 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Jul. 28, 2022	[5]	Jul. 28, 2022	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	250,000	[5]	250,000	[7]
Investment, cost	[2],[3],[6]	$ 250,000	[5]	$ 250,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Jul. 28, 2022	[5]	Jul. 28, 2022	[7]
Investment owned, cost	[2],[3],[6]	$ 250,000	[5]	$ 250,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 5 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[6]	Nov. 12, 2021	[5]	Feb. 27, 2020	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	500,000	[5]	1,000,000	[7]
Investment, cost	[2],[3],[6]	$ 500,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 2,256	[5]	$ 3,154	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[2],[3],[6]	Nov. 12, 2021	[5]	Feb. 27, 2020	[7]
Investment owned, cost	[2],[3],[6]	$ 500,000	[5]	$ 1,000,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 5 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Oct. 05, 2021	[5],[6]	Nov. 11, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	700,000	[5],[6]	400,000	[7],[8]
Investment, cost	[2],[3]	$ 700,000	[5],[6]	$ 400,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Oct. 05, 2021	[5],[6]	Nov. 11, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 700,000	[5],[6]	$ 400,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 17 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[6]	Jul. 12, 2019	[5]	Nov. 29, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	1,300,000	[5]	500,000	[7]
Investment, cost	[2],[3],[6]	$ 1,300,000	[5]	$ 500,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 5,864	[5]	$ 1,577	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[2],[3],[6]	Jul. 12, 2019	[5]	Nov. 29, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 1,300,000	[5]	$ 500,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 17 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Apr. 12, 2021	[5]	Oct. 20, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	1,200,000	[5]	1,000,000	[7]
Investment, cost	[2],[3],[6]	$ 1,200,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Apr. 12, 2021	[5]	Oct. 20, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 1,200,000	[5]	$ 1,000,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 11 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Mar. 30, 2022	[5],[6]	Jun. 10, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	150,000	[5],[6]	500,000	[7],[8]
Investment, cost	[2],[3]	$ 150,000	[5],[6]	$ 500,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 677	[5],[6]	$ 1,577	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Mar. 30, 2022	[5],[6]	Jun. 10, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 150,000	[5],[6]	$ 500,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 11 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Dec. 23, 2020	[5]	May 18, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	2,000,000	[5]	1,000,000	[7]
Investment, cost	[2],[3],[6]	$ 2,000,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7],[10]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Dec. 23, 2020	[5]	May 18, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 2,000,000	[5]	$ 1,000,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 23 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jun. 22, 2021	[5],[6]	May 10, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	250,000	[7],[8]
Investment, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 250,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jun. 22, 2021	[5],[6]	May 10, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 250,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Series AA Preferred Stock [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Investment, shares/par value (in shares)	[2],[3]	60,733,693	[4],[5]	60,733,693	[7]
Investment, cost	[2],[3]	$ 17,355,887	[4],[5]	$ 17,355,887	[7]
Investment, percent of net assets	[2],[3]	0	[4],[5]	0	[7]
Investment owned, cost	[2],[3]	$ 17,355,887	[4],[5]	$ 17,355,887	[7]
Series AA Preferred Stock [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member] | Minimum [Member]
Acquisition date	[2],[3]	Jun. 07, 2019	[4],[5]	Jun. 07, 2019	[7]
Acquisition date	[2],[3]	Jun. 07, 2019	[4],[5]	Jun. 07, 2019	[7]
Series AA Preferred Stock [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member] | Maximum [Member]
Acquisition date	[2],[3]	Jul. 20, 2020	[4],[5]	Jul. 20, 2020	[7]
Acquisition date	[2],[3]	Jul. 20, 2020	[4],[5]	Jul. 20, 2020	[7]
Preferred Stock [Member] | Equipment Leasing Sector [Member] | EQX Capital, Inc [Member]
Investment, shares/par value (in shares)	[2],[3],[4],[5]	1,950,000		1,950,000
Investment, cost	[2],[3],[4],[5]	$ 1,950,000		$ 1,950,000
Investment, percent of net assets	[2],[3],[4],[5]	63,148		110,172
Investment owned, cost	[2],[3],[4],[5]	$ 1,950,000		$ 1,950,000
Investment, percent of net assets		37.60%
Preferred Stock [Member] | Equipment Leasing Sector [Member] | EQX Capital, Inc [Member] | Minimum [Member]
Acquisition date	[2],[3],[5]	Jun. 10, 2016		Jun. 10, 2016	[4]
Acquisition date	[2],[3],[5]	Jun. 10, 2016		Jun. 10, 2016	[4]
Preferred Stock [Member] | Equipment Leasing Sector [Member] | EQX Capital, Inc [Member] | Maximum [Member]
Acquisition date	[2],[3],[5]	Nov. 07, 2016		Nov. 07, 2016	[4]
Acquisition date	[2],[3],[5]	Nov. 07, 2016		Nov. 07, 2016	[4]
Convertible Debt 29 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Aug. 12, 2020	[5]	Aug. 12, 2022	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	750,000	[5]	250,000	[7]
Investment, cost	[2],[3],[6]	$ 750,000	[5]	$ 250,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Aug. 12, 2020	[5]	Aug. 12, 2022	[7]
Investment owned, cost	[2],[3],[6]	$ 750,000	[5]	$ 250,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 6 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[3],[6]	Nov. 29, 2021	[2],[5]	Mar. 25, 2020	[7]
Investment, shares/par value (in shares)	[3],[6]	500,000	[2],[5]	500,000	[7]
Investment, cost	[2],[3],[6]	$ 500,000	[5]	$ 500,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 2,256	[5]	$ 1,577	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[10]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[3],[6]	Nov. 29, 2021	[2],[5]	Mar. 25, 2020	[7]
Investment owned, cost	[2],[3],[6]	$ 500,000	[5]	$ 500,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 6 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Nov. 11, 2020	[5],[6]	Nov. 24, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	400,000	[5],[6]	375,000	[7],[8]
Investment, cost	[2],[3]	$ 400,000	[5],[6]	$ 375,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Nov. 11, 2020	[5],[6]	Nov. 24, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 400,000	[5],[6]	$ 375,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 18 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[3],[6]	Jul. 16, 2021	[2],[5]	Feb. 08, 2022	[7]
Investment, shares/par value (in shares)	[3],[6]	500,000	[2],[5]	200,000	[7]
Investment, cost	[2],[3],[6]	$ 500,000	[5]	$ 200,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 2,256	[5]	$ 631	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[10]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[3],[6]	Jul. 16, 2021	[2],[5]	Feb. 08, 2022	[7]
Investment owned, cost	[2],[3],[6]	$ 500,000	[5]	$ 200,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 18 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[3],[6]	Apr. 14, 2022	[2],[5]	Nov. 23, 2021	[7]
Investment, shares/par value (in shares)	[3],[6]	65,000	[2],[5]	1,000,000	[7]
Investment, cost	[2],[3],[6]	$ 65,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[10]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[3],[6]	Apr. 14, 2022	[2],[5]	Nov. 23, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 65,000	[5]	$ 1,000,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 12 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Apr. 20, 2021	[5],[6]	Jul. 16, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	500,000	[7],[8]
Investment, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 500,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 4,511	[5],[6]	$ 1,577	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Apr. 20, 2021	[5],[6]	Jul. 16, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 500,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 12 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	Dec. 28, 2021	[5]	Jun. 22, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	1,000,000	[5]	1,000,000	[7]
Investment, cost	[2],[3],[6]	$ 1,000,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	Dec. 28, 2021	[5]	Jun. 22, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 1,000,000	[5]	$ 1,000,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 24 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jun. 28, 2022	[5],[6]	May 26, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	250,000	[5],[6]	250,000	[7],[8]
Investment, cost	[2],[3]	$ 250,000	[5],[6]	$ 250,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jun. 28, 2022	[5],[6]	May 26, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 250,000	[5],[6]	$ 250,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 30 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Aug. 12, 2022	[5],[6]	Oct. 21, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	250,000	[5],[6]	135,000	[7],[8]
Investment, cost	[2],[3]	$ 250,000	[5],[6]	$ 135,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Aug. 12, 2022	[5],[6]	Oct. 21, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 250,000	[5],[6]	$ 135,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 7 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[6]	Dec. 31, 2018	[5]	May 08, 2020	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	10,961,129	[5]	400,000	[7]
Investment, cost	[2],[3],[6]	$ 10,961,129	[5]	$ 400,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 49,448	[5]	$ 1,261	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[2],[3],[6]	Dec. 31, 2018	[5]	May 08, 2020	[7]
Investment owned, cost	[2],[3],[6]	$ 10,961,129	[5]	$ 400,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 7 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Nov. 14, 2022	[5],[6]	Dec. 11, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	165,000	[5],[6]	400,000	[7],[8]
Investment, cost	[2],[3]	$ 165,000	[5],[6]	$ 400,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Nov. 14, 2022	[5],[6]	Dec. 11, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 165,000	[5],[6]	$ 400,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 19 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[6]	Jul. 31, 2020	[5]	Mar. 30, 2022	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	500,000	[5]	150,000	[7]
Investment, cost	[2],[3],[6]	$ 500,000	[5]	$ 150,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 2,256	[5]	$ 473	[7]
Maturity date	[2],[3],[6]	Dec. 31, 2024	[5]	Dec. 31, 2024	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Acquisition date	[2],[3],[6]	Jul. 31, 2020	[5]	Mar. 30, 2022	[7]
Investment owned, cost	[2],[3],[6]	$ 500,000	[5]	$ 150,000	[7]
Interest rate	[2],[3],[6]	15%	[5]	15%	[7]
Convertible Debt 19 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[6]	May 10, 2022	[5]	Dec. 28, 2021	[7]
Investment, shares/par value (in shares)	[2],[3],[6]	2,500	[5]	1,000,000	[7]
Investment, cost	[2],[3],[6]	$ 250,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets	[2],[3],[6]	$ 0	[5]	$ 0	[7]
Maturity date	[2],[3],[6]	Jun. 30, 2024	[5]	Jun. 30, 2024	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Acquisition date	[2],[3],[6]	May 10, 2022	[5]	Dec. 28, 2021	[7]
Investment owned, cost	[2],[3],[6]	$ 250,000	[5]	$ 1,000,000	[7]
Interest rate	[2],[3],[6]	12%	[5]	12%	[7]
Convertible Debt 13 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Apr. 06, 2022	[5],[6]	Sep. 22, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	350,000	[5],[6]	500,000	[7],[8]
Investment, cost	[2],[3]	$ 350,000	[5],[6]	$ 500,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 1,579	[5],[6]	$ 1,577	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Apr. 06, 2022	[5],[6]	Sep. 22, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 350,000	[5],[6]	$ 500,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 13 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Dec. 09, 2022	[5],[6]	Jul. 26, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	125,000	[5],[6]	1,000,000	[7],[8]
Investment, cost	[2],[3]	$ 125,000	[5],[6]	$ 1,000,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Dec. 09, 2022	[5],[6]	Jul. 26, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 125,000	[5],[6]	$ 1,000,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 25 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jun. 07, 2019	[5],[6]	Jun. 10, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	4,929,015	[5],[6]	250,000	[7],[8]
Investment, cost	[2],[3]	$ 4,929,015	[5],[6]	$ 250,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jun. 07, 2019	[5],[6]	Jun. 10, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 4,929,015	[5],[6]	$ 250,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 31 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Aug. 19, 2021	[5],[6]	Nov. 11, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	10,000	[5],[6]	165,000	[7],[8]
Investment, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 165,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Aug. 19, 2021	[5],[6]	Nov. 11, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 165,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 1 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[5],[6]	Oct. 11, 2019		Dec. 31, 2018
Investment, shares/par value (in shares)	[2],[3],[5],[6]	500,000		10,961,129
Investment, cost	[2],[3],[5],[6]	$ 500,000		$ 10,961,129
Investment, percent of net assets		$ 2,255		$ 34,570
Maturity date	[2],[3],[5],[6]	Dec. 31, 2024		Dec. 31, 2024
Interest rate	[2],[3],[5],[6]	15%		15%
Acquisition date	[2],[3],[5],[6]	Oct. 11, 2019		Dec. 31, 2018
Investment owned, cost	[2],[3],[5],[6]	$ 500,000		$ 10,961,129
Interest rate	[2],[3],[5],[6]	15%		15%
Convertible Debt 1 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jan. 10, 2023	[5],[6]	Jun. 07, 2019	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	100,000	[5],[6]	4,929,015	[7],[8]
Investment, cost	[2],[3]	$ 100,000	[5],[6]	$ 4,929,015	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jan. 10, 2023	[5],[6]	Jun. 07, 2019	[7],[8]
Investment owned, cost	[2],[3]	$ 100,000	[5],[6]	$ 4,929,015	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 1 [Member] | Advanced Materials Sector [Member] | Kyma, INC. [Member]
Acquisition date				Mar. 01, 2019
Investment, shares/par value (in shares)	[3],[7]			100,000
Investment, cost	[3],[7]			$ 100,000
Investment, percent of net assets	[3],[7]			$ 100,000
Maturity date	[3],[7]			Mar. 30, 2024
Interest rate	[3],[7]			10%
Acquisition date				Mar. 01, 2019
Investment owned, cost	[3],[7]			$ 100,000
Interest rate	[3],[7]			10%
Convertible Debt 1 [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Acquisition date		Dec. 29, 2022	[2],[3],[5],[6]	Dec. 29, 2022
Investment, shares/par value (in shares)		5,359,791	[2],[3],[5],[6],[10]	1,200,000
Investment, cost		$ 5,359,791	[2],[3],[5],[6]	$ 1,200,000
Investment, percent of net assets		$ 2,580,617	[2],[3],[4],[5],[6]	$ 768,317
Maturity date		Dec. 31, 2024	[2],[3],[5],[6]	Dec. 31, 2024
Interest rate		10%	[2],[3],[5],[6]	10%
Acquisition date		Dec. 29, 2022	[2],[3],[5],[6]	Dec. 29, 2022
Investment owned, cost		$ 5,359,791	[2],[3],[5],[6]	$ 1,200,000
Interest rate		10%	[2],[3],[5],[6]	10%
Convertible Debt 8 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Feb. 27, 2020	[5],[6]	Jul. 31, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	500,000	[7],[8]
Investment, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 500,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 4,511	[5],[6]	$ 1,577	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Feb. 27, 2020	[5],[6]	Jul. 31, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 500,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 8 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Nov. 23, 2021	[5],[6]	Dec. 23, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	2,000,000	[7],[8]
Investment, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 2,000,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Nov. 23, 2021	[5],[6]	Dec. 23, 2020	[7],[8]
Investment owned, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 2,000,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 20 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Aug. 28, 2020	[5],[6]	Apr. 06, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	750,000	[5],[6]	350,000	[7],[8]
Investment, cost	[2],[3]	$ 750,000	[5],[6]	$ 350,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 3,383	[5],[6]	$ 1,104	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Aug. 28, 2020	[5],[6]	Apr. 06, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 750,000	[5],[6]	$ 350,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 20 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	May 18, 2021	[5],[6]	Feb. 23, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	200,000	[7],[8]
Investment, cost	[3]	$ 1,000,000	[5],[10]	$ 200,000	[2],[7],[8]
Investment, percent of net assets	[3]	$ 0	[5],[10]	$ 0	[2],[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	May 18, 2021	[5],[6]	Feb. 23, 2022	[7],[8]
Investment owned, cost	[3]	$ 1,000,000	[5],[10]	$ 200,000	[2],[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 14 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Mar. 08, 2020	[5],[6]	Oct. 06, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	400,000	[5],[6]	500,000	[7],[8]
Investment, cost	[2],[3]	$ 400,000	[5],[6]	$ 500,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 1,804	[5],[6]	$ 1,577	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Mar. 08, 2020	[5],[6]	Oct. 06, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 400,000	[5],[6]	$ 500,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 14 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[5],[6]	Feb. 23, 2021
Investment, shares/par value (in shares)	[2],[3]	1,400,000	[5],[6]	1,000,000	[7],[8]
Investment, cost	[2],[3]	$ 1,400,000	[5],[6]	$ 1,000,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3],[5],[6]	Feb. 23, 2021
Investment owned, cost	[2],[3]	$ 1,400,000	[5],[6]	$ 1,000,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 14 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member] | Maximum [Member]
Acquisition date	[2],[3],[7],[8]			Aug. 19, 2021
Acquisition date	[2],[3],[7],[8]			Aug. 19, 2021
Convertible Debt 26 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jul. 13, 2022	[5],[6]	Jun. 28, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	250,000	[5],[6]	250,000	[7],[8]
Investment, cost	[2],[3]	$ 250,000	[5],[6]	$ 250,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jul. 13, 2022	[5],[6]	Jun. 28, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 250,000	[5],[6]	$ 250,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 32 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Sep. 10, 2022	[5],[6]	Dec. 12, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	900,000	[5],[6]	125,000	[7],[8]
Investment, cost	[2],[3]	$ 900,000	[5],[6]	$ 125,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Sep. 10, 2022	[5],[6]	Dec. 12, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 900,000	[5],[6]	$ 125,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 21 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Sep. 22, 2021	[5],[6]	Jun. 10, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	500,000	[5],[6]	700,000	[7],[8]
Investment, cost	[2],[3]	$ 500,000	[5],[6]	$ 700,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 2,256	[5],[6]	$ 2,208	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Sep. 22, 2021	[5],[6]	Jun. 10, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 500,000	[5],[6]	$ 700,000	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 21 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	May 26, 2022	[5],[6]	Mar. 11, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	2,500	[5],[6]	185,000	[7],[8]
Investment, cost	[2],[3]	$ 250,000	[5],[6]	$ 185,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	May 26, 2022	[5],[6]	Mar. 11, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 250,000	[5],[6]	$ 185,000	[7],[8]
Investment, percent of net assets		601.90%
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 15 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Jun. 10, 2021	[5],[6]	Oct. 22, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	500,000	[5],[6]	1,000,000	[7],[8]
Investment, cost		$ 500,000		$ 1,000,000	[2],[3],[7],[8]
Investment, percent of net assets	[2],[3]	$ 2,256	[5],[6]	$ 3,154	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Acquisition date	[2],[3]	Jun. 10, 2021	[5],[6]	Oct. 22, 2021	[7],[8]
Investment owned, cost		$ 500,000		$ 1,000,000	[2],[3],[7],[8]
Interest rate	[2],[3]	15%	[5],[6]	15%	[7],[8]
Convertible Debt 15 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Feb. 23, 2022	[5],[6]	Sep. 22, 2021	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	200,000	[5],[6]	300,000	[7],[8]
Investment, cost	[2],[3]	$ 200,000	[5],[6]	$ 300,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Feb. 23, 2022	[5],[6]	Sep. 22, 2021	[7],[8]
Investment owned, cost	[2],[3]	$ 200,000	[5],[6]	$ 300,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 27 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Jul. 26, 2021	[5],[6]	Jul. 13, 2022	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	250,000	[7],[8]
Investment, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 250,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Jul. 26, 2021	[5],[6]	Jul. 13, 2022	[7],[8]
Investment owned, cost	[2],[3]	$ 1,000,000	[5],[6]	$ 250,000	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 2 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date		Oct. 22, 2021	[2],[3],[5],[6]	Jul. 12, 2019
Investment, shares/par value (in shares)		10,000	[2],[3],[5],[6]	13,000
Investment, cost		$ 10,000	[2],[3],[5],[6]	$ 13,000
Investment, percent of net assets		$ 45.11		$ 41
Maturity date		Dec. 31, 2024	[2],[3],[5],[6]	Dec. 31, 2024
Interest rate		15%	[2],[3],[5],[6]	15%
Acquisition date		Oct. 22, 2021	[2],[3],[5],[6]	Jul. 12, 2019
Investment owned, cost		$ 10,000	[2],[3],[5],[6]	$ 13,000
Interest rate		15%	[2],[3],[5],[6]	15%
Convertible Debt 2 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3]	Oct. 23, 2020	[5],[6]	Aug. 12, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,050,000	[5],[6]	750,000	[7],[8]
Investment, cost	[3]	$ 1,050,000	[5],[6],[10]	$ 750,000	[2],[7],[8]
Investment, percent of net assets	[3]	$ 0	[5],[6],[10]	$ 0	[2],[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Acquisition date	[2],[3]	Oct. 23, 2020	[5],[6]	Aug. 12, 2020	[7],[8]
Investment owned, cost	[3]	$ 1,050,000	[5],[6],[10]	$ 750,000	[2],[7],[8]
Interest rate	[2],[3]	12%	[5],[6]	12%	[7],[8]
Convertible Debt 2 [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Acquisition date	[2],[3],[5]	Dec. 29, 2022		Dec. 29, 2022	[6]
Investment, shares/par value (in shares)	[2],[3],[5]	1,200,000		5,359,791	[6]
Investment, cost	[3],[5]	$ 1,200,000	[2]	$ 5,359,791	[6],[10]
Investment, percent of net assets		$ 577,772	[2],[3],[4],[5]	$ 3,431,683
Maturity date	[2],[3],[5]	Dec. 31, 2024		Dec. 31, 2024	[6]
Interest rate	[2],[3],[5]	10%		10%	[6]
Acquisition date	[2],[3],[5]	Dec. 29, 2022		Dec. 29, 2022	[6]
Investment owned, cost	[3],[5]	$ 1,200,000	[2]	$ 5,359,791	[6],[10]
Investment, percent of net assets		1,880.90%
Interest rate	[2],[3],[5]	10%		10%	[6]
Series C Preferred Stock [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Jul. 12, 2013	[5]	Jul. 12, 2013	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	26,856,187	[5]	26,856,187	[7],[8]
Investment, cost	[2],[3]	$ 26,299,939	[5]	$ 26,299,938	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5]	$ 0	[7],[8]
Acquisition date	[2],[3]	Jul. 12, 2013	[5]	Jul. 12, 2013	[7],[8]
Investment owned, cost	[2],[3]	$ 26,299,939	[5]	$ 26,299,938	[7],[8]
Series C Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Investment, shares/par value (in shares)	[2],[3],[5]	2,650,000		2,650,000	[4]
Investment, cost	[2],[3],[4],[5]	$ 2,650,000		$ 2,650,000
Investment, percent of net assets	[2],[3],[5]	0		0	[4]
Investment owned, cost	[2],[3],[4],[5]	$ 2,650,000		$ 2,650,000
Series C Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member] | Minimum [Member]
Acquisition date	[2],[3],[5]	Aug. 07, 2019		Aug. 07, 2019
Acquisition date	[2],[3],[5]	Aug. 07, 2019		Aug. 07, 2019
Series C Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member] | Maximum [Member]
Acquisition date	[2],[3],[5]	Feb. 12, 2020		Feb. 12, 2020
Acquisition date	[2],[3],[5]	Feb. 12, 2020		Feb. 12, 2020
Series A Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Acquisition date	[2],[3],[5]	Sep. 18, 2015		Sep. 19, 2015
Investment, shares/par value (in shares)	[2],[3],[5]	3,642,324	[4]	3,642,324
Investment, cost	[2],[3],[5]	$ 2,000,000		$ 2,000,000
Investment, percent of net assets	[2],[3],[5]	$ 0		$ 0	[4]
Acquisition date	[2],[3],[5]	Sep. 18, 2015		Sep. 19, 2015
Investment owned, cost	[2],[3],[5]	$ 2,000,000		$ 2,000,000
Series AA Preferred Stock Warrants [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[7]			Jun. 07, 2019
Investment, shares/par value (in shares)	[2],[3],[7]			609,756
Investment, cost	[2],[3],[7]			$ 0
Investment, percent of net assets	[2],[3],[7]			$ 0
Acquisition date	[2],[3],[7]			Jun. 07, 2019
Investment owned, cost	[2],[3],[7]			$ 0
Series AA Preferred Stock Warrants [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Investment, shares/par value (in shares)	[2],[3],[5]	12,250,000	[4]	12,250,000
Investment, cost	[2],[3],[4],[5]	$ 0		$ 0
Investment, percent of net assets	[2],[3],[5]	0	[4]	0
Investment owned, cost	[2],[3],[4],[5]	$ 0		$ 0
Series AA Preferred Stock Warrants [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member] | Minimum [Member]
Acquisition date	[2],[3],[5]	Jul. 09, 2018		Jul. 09, 2018
Acquisition date	[2],[3],[5]	Jul. 09, 2018		Jul. 09, 2018
Series AA Preferred Stock Warrants [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member] | Maximum [Member]
Acquisition date	[2],[3],[5]	Sep. 04, 2018		Sep. 04, 2018
Acquisition date	[2],[3],[5]	Sep. 04, 2018		Sep. 04, 2018
Term Note [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Feb. 10, 2017	[5],[6]	Feb. 28, 2014	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	2,000,000	[5],[6]	3,000,000	[7],[8]
Investment, cost	[2],[3]	$ 2,000,000	[5],[6]	$ 3,000,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 9,022	[5],[6]	$ 9,461	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	8%	[5],[6]	8%	[7],[8]
Acquisition date	[2],[3]	Feb. 10, 2017	[5],[6]	Feb. 28, 2014	[7],[8]
Investment owned, cost	[2],[3]	$ 2,000,000	[5],[6]	$ 3,000,000	[7],[8]
Interest rate	[2],[3]	8%	[5],[6]	8%	[7],[8]
Series B Preferred Stock [Member] | Semiconductor Equipment Sector [Member] | Lyncean Technologies, Inc. [Member]
Acquisition date		Jul. 03, 2018	[3],[5]	Jul. 03, 2018
Investment, shares/par value (in shares)	[3]	869,792	[5]	869,792	[7]
Investment, cost	[3]	$ 1,000,000	[5]	$ 1,000,000	[7]
Investment, percent of net assets		$ 0		$ 0	[3],[7]
Acquisition date		Jul. 03, 2018	[3],[5]	Jul. 03, 2018
Investment owned, cost	[3]	$ 1,000,000	[5]	$ 1,000,000	[7]
Series B Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Investment, shares/par value (in shares)	[2],[3],[4],[5]	7,039,203		7,039,203
Investment, cost	[2],[3],[5]	$ 6,587,102	[4]	$ 6,587,102
Investment, percent of net assets	[2],[3],[5]	0	[4]	0
Investment owned, cost	[2],[3],[5]	$ 6,587,102	[4]	$ 6,587,102
Series B Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member] | Minimum [Member]
Acquisition date	[2],[3],[5]	Aug. 07, 2017		Aug. 07, 2017
Acquisition date	[2],[3],[5]	Aug. 07, 2017		Aug. 07, 2017
Series B Preferred Stock [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member] | Maximum [Member]
Acquisition date	[2],[3],[5]	Feb. 01, 2019		Feb. 01, 2019
Acquisition date	[2],[3],[5]	Feb. 01, 2019		Feb. 01, 2019
Convertible Debt 3 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3],[5],[6]	Oct. 29, 2019		Oct. 11, 2019
Investment, shares/par value (in shares)	[2],[3],[5],[6]	5,000		5,000
Investment, cost	[2],[3],[5],[6]	$ 5,000	[4]	$ 5,000
Investment, percent of net assets		$ 22.55		$ 15.77
Maturity date	[2],[3],[5],[6]	Dec. 31, 2024		Dec. 31, 2024
Interest rate	[2],[3],[5],[6]	15%		15%
Acquisition date	[2],[3],[5],[6]	Oct. 29, 2019		Oct. 11, 2019
Investment owned, cost	[2],[3],[5],[6]	$ 5,000	[4]	$ 5,000
Interest rate	[2],[3],[5],[6]	15%		15%
Convertible Debt 3 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[3]	Oct. 20, 2021	[2],[5],[6]	Sep. 10, 2020	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	1,000,000	[5],[6]	900,000	[7],[8]
Investment, cost	[3]	$ 1,000,000	[2],[5],[6]	$ 900,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 0	[5],[6]	$ 0	[7],[8]
Maturity date	[2],[3]	Jun. 30, 2024	[5],[6]	Jun. 30, 2024	[7],[8]
Interest rate	[3]	12%	[2],[5],[6]	12%	[7],[8],[10]
Acquisition date	[3]	Oct. 20, 2021	[2],[5],[6]	Sep. 10, 2020	[7],[8]
Investment owned, cost	[3]	$ 1,000,000	[2],[5],[6]	$ 900,000	[7],[8]
Interest rate	[3]	12%	[2],[5],[6]	12%	[7],[8],[10]
Term Note 2 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Acquisition date	[2],[3]	Feb. 28, 2014	[5],[6]	Feb. 10, 2017	[7],[8]
Investment, shares/par value (in shares)	[2],[3]	3,000,000	[5],[6]	2,000,000	[7],[8]
Investment, cost	[2],[3]	$ 3,000,000	[5],[6]	$ 2,000,000	[7],[8]
Investment, percent of net assets	[2],[3]	$ 13,534	[5],[6]	$ 6,308	[7],[8]
Maturity date	[2],[3]	Dec. 31, 2024	[5],[6]	Dec. 31, 2024	[7],[8]
Interest rate	[2],[3]	8%	[5],[6]	8%	[7],[8]
Acquisition date	[2],[3]	Feb. 28, 2014	[5],[6]	Feb. 10, 2017	[7],[8]
Investment owned, cost	[2],[3]	$ 3,000,000	[5],[6]	$ 2,000,000	[7],[8]
Interest rate	[2],[3]	8%	[5],[6]	8%	[7],[8]
Series B Preferred Stock Warrants 2 [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Acquisition date	[2],[3],[5]	Feb. 01, 2019		Feb. 01, 2019
Investment, shares/par value (in shares)	[2],[3],[4],[5]	5,250,000		5,250,000
Investment, cost	[2],[3],[4],[5]	$ 0		$ 0
Investment, percent of net assets	[2],[3],[4],[5]	$ 0		$ 0
Acquisition date	[2],[3],[5]	Feb. 01, 2019		Feb. 01, 2019
Investment owned, cost	[2],[3],[4],[5]	$ 0		$ 0
Convertible Debt 33 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Acquisition date	[2],[3],[5],[6]	Sep. 22, 2021
Investment, shares/par value (in shares)	[2],[3],[5],[6]	3,000
Investment, cost	[2],[3],[5],[6]	$ 300,000
Investment, percent of net assets	[2],[3],[5],[6]	$ 0
Maturity date	[2],[3],[5],[6]	Jun. 30, 2024
Interest rate	[2],[3],[5],[6]	12%
Acquisition date	[2],[3],[5],[6]	Sep. 22, 2021
Investment owned, cost	[2],[3],[5],[6]	$ 300,000
Interest rate	[2],[3],[5],[6]	12%
Series B Preferred Stock Warrants 3 [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Acquisition date	[2],[3],[5]	Aug. 07, 2017		Aug. 08, 2017
Investment, shares/par value (in shares)	[2],[3],[4],[5]	6,214,922		6,214,922
Investment, cost	[2],[3],[4],[5]	$ 0		$ 0
Investment, percent of net assets	[2],[3],[4],[5]	$ 0		$ 0
Acquisition date	[2],[3],[5]	Aug. 07, 2017		Aug. 08, 2017
Investment owned, cost	[2],[3],[4],[5]	$ 0		$ 0
Series B Preferred Stock Warrants 4 [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Acquisition date	[2],[3],[5]	Sep. 28, 2017	[4]	Sep. 28, 2017
Investment, shares/par value (in shares)	[2],[3],[4],[5]	700,000		700,000
Investment, cost	[2],[3],[4]	$ 0	[6]	$ 0	[5]
Investment, percent of net assets	[2],[3],[4],[5]	$ 0		$ 0
Acquisition date	[2],[3],[5]	Sep. 28, 2017	[4]	Sep. 28, 2017
Investment owned, cost	[2],[3],[4]	$ 0	[6]	$ 0	[5]
[1]Includes warrants whose primary risk exposure is equity contracts.[2]Controlled investments.[3]Fair Value Level 3 security (2770.7% of net assets)[4]Non-income producing security.[5]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (see Note 3). At March 31, 2024, we held $3,641,844 (or 2168.8% of net assets) in restricted securities (see Note 2).[6]Security whose interest accrues until maturity however, based on March 31, 2024 valuation no such interest accrued during period ended March 31, 2024.[7]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At December 31, 2023, we held $4,797,872 (or 380.7% of net assets) in restricted securities (see Note 2).[8]Security whose interest accrues until maturity however, based on December 31, 2023 valuation no such interest accrued during year ended December 31, 2023.[9]The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.[10]Affiliated issuer.

Consolidated Schedule of Inve_5

Consolidated Schedule of Investments - Schedule of Investments (Details) (Parentheticals) - USD ($)		Mar. 31, 2024		Dec. 31, 2023
Investment, percent of net assets		2,796.40%		693%
Investment, percent of net assets	[1]	$ 4,695,742		$ 8,733,779
Investment, cost		$ 133,837,406		$ 133,967,669
Liabilities percentage of net asset value		2,696.40%		593%
Total percentage of net asset value		100%		100%
Equipment Leasing Sector [Member] | EQX Capital, Inc [Member]
Investment, percent of net assets				8.80%
Investment, percent of net assets		$ 63,157		$ 110,227	[2],[3],[4],[5]
Semiconductor Equipment Sector [Member] | Revasum, Inc [Member]
Investment, percent of net assets		601.90%		306.50%
Investment, percent of net assets		$ 31,583.89
Semiconductor Equipment Sector [Member] | Lyncean Technologies, Inc. [Member]
Investment, percent of net assets				0%
Investment, percent of net assets		$ 0
Investment Sector [Member] | Fidelity Investments [Member]
Investment, percent of net assets		25.70%		5.80%
Investment, percent of net assets	[6]	$ 43,239		$ 73,502
Investment, cost	[6]	$ 43,239		$ 73,502
Advanced Materials Sector [Member] | UCT Coatings, Inc. [Member]
Investment, percent of net assets		175.60%		23.80%
Advanced Materials Sector [Member] | Kyma, INC. [Member]
Investment, percent of net assets				7.90%
Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Investment, percent of net assets				333.20%
Investment, percent of net assets	[2],[3],[4],[5]			$ 4,200,000
Investment, cost	[2],[3],[4],[7]
Automotive Sector [Member] | Wrightspeed Inc [Member]
Investment, percent of net assets		0%		0%
Investment, percent of net assets		$ 0	[2],[3],[5],[7]	$ 0
Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Investment, percent of net assets		74.70%		7%
Investment, percent of net assets	[2],[3]	$ 125,462	[5],[7]	$ 87,713	[8],[9]
Investment, cost	[2],[3],[5],[7]
Preferred Stock [Member] | Equipment Leasing Sector [Member] | EQX Capital, Inc [Member]
Investment, percent of net assets		37.60%
Investment, percent of net assets	[2],[3],[4],[5]	$ 63,148		110,172
Investment, cost	[2],[3],[4],[5]	$ 1,950,000		1,950,000
Convertible Debt 2 [Member] | Aerospace Sector [Member] | Hera Systems, Inc. [Member]
Investment, percent of net assets		1,880.90%
Investment, percent of net assets		$ 577,772	[2],[3],[4],[5]	3,431,683
Investment, cost	[3],[5]	1,200,000	[2]	5,359,791	[7],[10]
Convertible Debt 2 [Member] | Automotive Sector [Member] | Wrightspeed Inc [Member]
Investment, percent of net assets	[3]	0	[5],[7],[10]	0	[2],[8],[9]
Investment, cost	[3]	1,050,000	[5],[7],[10]	750,000	[2],[8],[9]
Convertible Debt 2 [Member] | Medical Devices Sector [Member] | IntraOp Medical Corp. [Member]
Investment, percent of net assets		45.11		41
Investment, cost		$ 10,000	[2],[3],[5],[7]	$ 13,000
[1]Includes warrants whose primary risk exposure is equity contracts.[2]Controlled investments.[3]Fair Value Level 3 security (2770.7% of net assets)[4]Non-income producing security.[5]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (see Note 3). At March 31, 2024, we held $3,641,844 (or 2168.8% of net assets) in restricted securities (see Note 2).[6]The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.[7]Security whose interest accrues until maturity however, based on March 31, 2024 valuation no such interest accrued during period ended March 31, 2024.[8]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At December 31, 2023, we held $4,797,872 (or 380.7% of net assets) in restricted securities (see Note 2).[9]Security whose interest accrues until maturity however, based on December 31, 2023 valuation no such interest accrued during year ended December 31, 2023.[10]Affiliated issuer.

Note 1 - The Company (Details T

Note 1 - The Company (Details Textual)				3 Months Ended	12 Months Ended
		Dec. 17, 2018	Apr. 18, 2011	Mar. 31, 2024 USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2023 USD ($)
Operations Commenced Date			Apr. 18, 2011
Investment Owned, Net Assets, Percentage				2,796.40%			693%
Investment Owned, Fair Value	[1]			$ 4,695,742			$ 8,733,779
Cayman Subsidiaries [Member]
Number of Subsidiaries		3
Subsidiaries [Member]
Number of Subsidiaries					3	3
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Technology Sector [Member]
Concentration Risk, Percentage				50%
Minimum [Member] | Technology Sector [Member]
Investment Owned, Fair Value				$ 1,000,000
Maximum [Member] | Technology Sector [Member]
Investment Owned, Fair Value				10,000,000
Investment, Affiliated Issuer, Controlled [Member]
Investment Owned, Fair Value				$ 4,357,667			$ 8,260,345
Technology Companies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Minimum [Member]
Investment Owned, Net Assets, Percentage				80%
Small-cap Stocks Companies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Minimum [Member]
Investment Owned, Net Assets, Percentage				70%
[1]Includes warrants whose primary risk exposure is equity contracts.

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)		Mar. 31, 2024	Dec. 31, 2023
Investment Owned, Fair Value	[1]	$ 4,695,742	$ 8,733,779
Deferred Compensation Arrangement, Percent of Compensation Deferred		50%
Venture Capital Funds [Member]
Investment Owned, Fair Value		$ 4,700,000
Restricted Securities [Member]
Investment Owned, Fair Value		$ 3,641,844	$ 4,797,872
[1]Includes warrants whose primary risk exposure is equity contracts.

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Schedule of Derivatives (Details)	Mar. 31, 2024
Purchased Options [Member]
Firsthand Technology Value Fund, Inc.	0
Warrant [Member]
Firsthand Technology Value Fund, Inc.	0
Written Options [Member]
Firsthand Technology Value Fund, Inc.	0

Note 4 - Investment Managemen_2

Note 4 - Investment Management Fee (Details Textual) - USD ($)			3 Months Ended
	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2024	Dec. 31, 2023
Management Fee Payable	$ 277		$ 277	$ 0
Management [Member]
Management and Service Fees, Rate			2%
Management and Service Fees, Incentive Rate			20%
Increase (Decrease) in Incentive Fee Payable			$ 0
Management Fee Payable	3,000,000	$ 2,500,000	$ 3,000,000
Investment Company, Contractual Fee Waived	$ 3	$ 2,500,000

Note 6 - Fair value (Details Te

Note 6 - Fair value (Details Textual)	3 Months Ended
	Mar. 31, 2024 USD ($)
Fair Value, Inputs, Level 3 [Member]
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ (3,907,774)	[1]
[1]The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of March 31, 2024 was $(3,907,774).

Note 6 - Fair Value - Schedule

Note 6 - Fair Value - Schedule of Balance Sheet Grouping (Details) - USD ($)		Mar. 31, 2024	Dec. 31, 2023
Investments, fair value	[1]	$ 4,695,742	$ 8,733,779
Fair Value, Inputs, Level 1 [Member]
Investments, fair value		43,239
Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Fair Value, Inputs, Level 3 [Member]
Investments, fair value		4,652,503
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		300,000
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		63,148
Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		1,000,000
Aerospace Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		3,200,000
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		100,000
Common Stock [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Common Stock [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Common Stock [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		1,305,504
Common Stock [Member] | Advanced Materials Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Common Stock [Member] | Advanced Materials Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Common Stock [Member] | Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		294,836
Common Stock [Member] | Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Common Stock [Member] | Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Common Stock [Member] | Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		9
Common Stock [Member] | Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Common Stock [Member] | Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Common Stock [Member] | Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		1,010,659
Preferred Stock [Member] | Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Preferred Stock [Member] | Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Preferred Stock [Member] | Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		63,148
Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value	[2]	0
Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member] | Equity Contract [Member]
Investments, fair value		0
Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value	[2]	0
Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member] | Equity Contract [Member]
Investments, fair value		0
Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value	[2]	0
Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Contract [Member]
Investments, fair value		0
Debt [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Debt [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Debt [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		3,283,851
Debt [Member] | Aerospace Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Debt [Member] | Aerospace Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Debt [Member] | Aerospace Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		3,158,389
Debt [Member] | Medical Devices Sector [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		0
Debt [Member] | Medical Devices Sector [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Debt [Member] | Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		125,462
Mutual Fund [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value		43,239
Mutual Fund [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value		0
Mutual Fund [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 0
[1]Includes warrants whose primary risk exposure is equity contracts.[2]Asset derivatives include warrants.

Note 6 - Fair Value - Reconcili

Note 6 - Fair Value - Reconciliation of Level 3 Assets (Details) - Fair Value, Inputs, Level 3 [Member]	3 Months Ended
	Mar. 31, 2024 USD ($)
Fair value, balance	$ 4,797,872
Purchases	0
Sales	(100,000)
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(3,907,774)	[1]
Transfers	3,862,405
Fair value, balance	4,652,503
Common Stock [Member]
Fair value, balance	299,987
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(2,856,888)	[1]
Transfers	3,862,405
Fair value, balance	1,305,504
Common Stock [Member] | Advanced Materials Sector [Member]
Fair value, balance	299,932
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(5,096)	[1]
Transfers	0
Fair value, balance	294,836
Common Stock [Member] | Equipment Leasing Sector [Member]
Fair value, balance	55
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(46)	[1]
Transfers	0
Fair value, balance	9
Common Stock [Member] | Semiconductor Equipment Sector [Member]
Fair value, balance	0
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(2,851,746)
Transfers	3,862,405
Fair value, balance	1,010,659
Preferred Stock [Member]
Fair value, balance	110,172
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(47,024)	[1]
Transfers	0
Fair value, balance	63,148
Preferred Stock [Member] | Equipment Leasing Sector [Member]
Fair value, balance	110,172
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(47,204)	[1]
Transfers	0
Fair value, balance	63,148
Preferred Stock [Member] | Aerospace Sector [Member]
Fair value, balance	4,200,000
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(1,041,611)	[1]
Transfers	0
Fair value, balance	3,158,389
Debt [Member] | Advanced Materials Sector [Member]
Fair value, balance	100,000
Purchases	0
Sales	(100,000)
Realized gains (losses)	0
Unrealized appreciation (depreciation)	0	[1]
Transfers	0
Fair value, balance	0
Convertible Debt [Member]
Fair value, balance	4,387,713
Purchases	0
Sales	(100,000)
Realized gains (losses)	0
Unrealized appreciation (depreciation)	(1,003,862)
Transfers	0
Fair value, balance	3,283,851
Convertible Debt [Member] | Medical Devices Sector [Member]
Fair value, balance	87,713
Purchases	0
Sales	0
Realized gains (losses)	0
Unrealized appreciation (depreciation)	37,749	[1]
Transfers	0
Fair value, balance	$ 125,462
[1]The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of March 31, 2024 was $(3,907,774).

Note 6 - Fair Value - Schedul_2

Note 6 - Fair Value - Schedule of Valuation Techniques and Assumptions (Details)		Mar. 31, 2024 USD ($) yr	Dec. 31, 2023 USD ($)
Investments, fair value	[1]	$ 4,695,742	$ 8,733,779
Fair Value, Inputs, Level 3 [Member]
Investments, fair value		4,652,503
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 300,000
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Revenue Multiple [Member] | Minimum [Member]
Measurement Input	[2]	0.8
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Revenue Multiple [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	0.9
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Expected Term [Member] | Minimum [Member]
Measurement Input | yr	[2]	5
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Expected Term [Member] | Weighted Average [Member]
Measurement Input | yr	[2],[3]	5
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Measurement Input	[2]	50
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	50
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Measurement Input	[2]	4.21
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	4.21
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Minimum [Member]
Measurement Input	[4]	22.9
Advanced Materials Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Weighted Average [Member]
Measurement Input	[3],[4]	22.9
Aerospace Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 3,200,000
Aerospace Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, EBITDA Multiple [Member] | Minimum [Member]
Measurement Input	[2]	1.9
Aerospace Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, EBITDA Multiple [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	1.9
Automotive Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 0
Automotive Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Liquidation Value [Member] | Measurement input, Market Value of Invested Capital [Member] | Minimum [Member]
Measurement Input	[2]	0
Automotive Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Liquidation Value [Member] | Measurement input, Market Value of Invested Capital [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	0
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 63,148
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Measurement Input	[2]	50
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	50
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Measurement Input	[2]	4.21
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	4.21
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Expected Term [Member] | Minimum [Member]
Measurement Input | yr	[2]	5
Equipment Leasing Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Expected Term [Member] | Weighted Average [Member]
Measurement Input | yr	[2],[3]	5
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 100,000
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Revenue Multiple [Member] | Minimum [Member]
Measurement Input	[2]	1.8
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Revenue Multiple [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	1.9
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Measurement Input	[2]	4.4
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Risk Free Interest Rate [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	4.4
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Going Concern Probability [Member] | Minimum [Member]
Measurement Input	[2]	10
Medical Devices Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation, Market Approach [Member] | Measurement Input, Going Concern Probability [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	10
Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value		$ 1,000,000
Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Public Market Price [Member] | Measurement Input, Share Price [Member] | Minimum [Member]
Measurement Input	[2]	25
Semiconductor Equipment Sector [Member] | Fair Value, Inputs, Level 3 [Member] | Valuation Technique, Public Market Price [Member] | Measurement Input, Share Price [Member] | Weighted Average [Member]
Measurement Input	[2],[3]	25
[1]Includes warrants whose primary risk exposure is equity contracts.[2]An increase in the input would result in an increase in the security’s valuation; a decrease in the input would result in a decrease in the security’s valuation.[3]Weighted average is calculated by weighting the significant unobservable input by the relative fair value of each investment in the category[4]An increase in the input would result in a decrease in the security’s valuation; a decrease in the input would result in an increase in the security’s valuation.

Note 7 - Federal Income Taxes_2

Note 7 - Federal Income Taxes (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21%	21%	21%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	6.98%
Effective Income Tax Rate Reconciliation, Percent	0%	0%	0%
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued			$ 0
Unrecognized Tax Benefits			0
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit			0
Operating Loss Carryforwards			$ 12,387,144
Operating Loss Carryforwards, Period (Year)			5 years
Difference in Tax Rate Due to changes in Deferred Tax Assets [Member]
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent			27.98%

Note 7 - Federal Income Taxes -

Note 7 - Federal Income Taxes - Schedule of Tax Cost of Investments (Details)	Mar. 31, 2024 USD ($)
Gross unrealized appreciation	$ 0
Gross unrealized depreciation	(129,141,664)
Net unrealized depreciation	(129,141,664)
Federal income tax cost, Investments	$ 133,837,406

Note 7 - Federal Income Taxes_3

Note 7 - Federal Income Taxes - Schedule of Income tax Provision (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)
Federal	$ 0
State	0
Total deferred tax (expense)/benefit	$ 0

Note 7 - Federal Income Taxes_4

Note 7 - Federal Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)	Mar. 31, 2024 USD ($)
Net operating loss carryforward	$ 3,465,923
Capital loss carryforward	9,161,034
Net unrealized losses (gains) on investment securities	35,040,442
Total deferred tax assets, net	47,667,399
Valuation allowance	(47,667,399)
Net	$ 0

Note 7 - Federal Income Taxes_5

Note 7 - Federal Income Taxes - Schedule of Tax Rate (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Effective tax rate	0%	0%	0%
Statutory federal income tax rate	21%	21%	21%

Note 7 - Federal Income Taxes_6

Note 7 - Federal Income Taxes - Schedule of Capital Loss Carryforwards (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Capital loss carryforwards		$ 12,387,144
Capital Loss Carryforward [Member]
Capital loss carryforwards	$ 32,741,364
Carryforward, Expiration Date 1 [Member] | Capital Loss Carryforward [Member]
Expiration date	Dec. 31, 2024
Capital loss carryforwards	$ 14,230,073
Carryforward, Expiration Date 2 [Member] | Capital Loss Carryforward [Member]
Expiration date	Dec. 31, 2025
Capital loss carryforwards	$ 7,516,642
Carryforward, Expiration Date 3 [Member] | Capital Loss Carryforward [Member]
Expiration date	Dec. 31, 2027
Capital loss carryforwards	$ 3,129,665
Carryforward, Expiration Date 4 [Member] | Capital Loss Carryforward [Member]
Expiration date	Dec. 31, 2025
Capital loss carryforwards	$ 7,864,982

Note 8 - Investment Transacti_3

Note 8 - Investment Transactions - Schedule of Investments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Purchase of investment securities	$ 0
Proceeds from sales and maturities of investment securities	$ (100,000)	$ (498,424)

Note 9 - Share Buybacks (Detail

Note 9 - Share Buybacks (Details Textual) - USD ($)

1 Months Ended

2 Months Ended

3 Months Ended

Feb. 14, 2020

Dec. 16, 2019

Oct. 24, 2018

Nov. 10, 2017

Apr. 26, 2016

Dec. 22, 2014

Sep. 30, 2016

Dec. 31, 2017

Mar. 31, 2024

Mar. 31, 2023

Dec. 31, 2023

Mar. 31, 2020

Dec. 31, 2018

Aug. 31, 2018

Dec. 31, 2014

Shares, Outstanding (in shares)

7,016,432

7,016,432

Stock Repurchased During Period, Shares (in shares)

0

0

Investment Company, Share Repurchase Plan [Member]

Repurchase Agreement, Date

Nov. 10, 2017

Apr. 26, 2016

Repurchase Agreement, Date of Repurchase

Aug. 31, 2018

Sep. 30, 2016

Stock Repurchased and Retired During Period, Shares (in shares)

272,008

128,551

Stock Repurchased During Period, Value

$ 2,000,000

$ 1,100,000

Shares, Outstanding (in shares)

7,302,146

Investment Company, Share Repurchase Plan [Member] | Maximum [Member]

Stock Repurchase Program, Authorized Amount

$ 2,000,000

$ 2,000,000

$ 2,000,000

Investment Company, Modified Dutch Auction Tender Offer [Member]

Stock Repurchase Program, Authorized Amount

$ 2,000,000

$ 5,044,728

Stock Repurchased During Period, Value

$ 2,000,000

Shares, Outstanding (in shares)

6,893,056

7,178,770

Stock Repurchased During Period, Shares (in shares)

285,714

123,376

859,468

Investment Company, Share Repurchase, Per Share (in dollars per share)

$ 7

$ 0.1

$ 16.21

Stock Repurchase, Purchase Price of Common Stock, Percent

95%

Shares Issued, Price Per Share (in dollars per share)

$ 23.2702

Investment Company, Modified Dutch Auction Tender Offer [Member] | Maximum [Member]

Investment Company, Share Repurchase, Per Share (in dollars per share)

8

Investment Company, Modified Dutch Auction Tender Offer [Member] | Minimum [Member]

Investment Company, Share Repurchase, Per Share (in dollars per share)

$ 6

Investment Company, Tender Offer [Member] | Maximum [Member]

Stock Repurchase Program, Authorized Amount

$ 20,000,000

Note 10 - Investments in Affi_3

Note 10 - Investments in Affiliates and Controlled Investments - Schedule of Controlled Investments (Details) - USD ($)		3 Months Ended
		Mar. 31, 2024		Mar. 31, 2023	Dec. 31, 2023
Investments, fair value	[1]	$ 8,733,779
Net realized gain (loss) from security transactions and foreign currency		0		$ (7,864,997)
Net change in unrealized appreciation (depreciation) on investments		(3,907,923)		$ 3,320,862
Investments, fair value	[1]	4,695,742
Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value		8,260,345
Purchase/merger
Interest		30,000
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(3,902,678)
Investments, fair value		4,357,667
Investment, Affiliated Issuer and Controlled [Member]
Investments, fair value		8,560,277
Interest		30,000
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(3,907,774)
Investments, fair value		4,652,503
Investment, Affiliated Issuer [Member]
Investments, fair value		299,932
Interest		0
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(5,096)
Investments, fair value		294,836
Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value		87,713
Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger
Interest		0
Sales/maturity/expiration
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		37,749
Investments, fair value		$ 125,462
Shares held (in shares)
Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value		$ 0
Interest		0
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		0
Investments, fair value		0
Equipment Leasing Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value		110,227
Equipment Leasing Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Interest		0
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(47,070)
Investments, fair value		63,157
Advanced Materials Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value		299,932
Advanced Materials Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Interest		0
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(5,096)
Investments, fair value		294,836
Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value		4,200,000
Interest		30,000
Sales/maturity/expiration
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(1,041,611)
Investments, fair value		3,158,389
Semiconductor Equipment Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value		3,862,405
Semiconductor Equipment Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Interest		0
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(2,851,746)
Investments, fair value		$ 1,010,659
Shares held (in shares)
IntraOp Medical Corp. [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 87,713
Investments, fair value	[2],[3],[6],[7]	$ 125,462
Shares held (in shares)	[2],[3],[6],[7]
IntraOp Medical Corp. [Member] | Convertible Debt 1 [Member] | Medical Devices Sector [Member]
Investments, fair value		$ 34,570
Investments, fair value		$ 2,255
Shares held (in shares)	[2],[3],[6],[7]	500,000			10,961,129
IntraOp Medical Corp. [Member] | Convertible Debt 1 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 34,570
IntraOp Medical Corp. [Member] | Convertible Debt 1 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	14,878
Investments, fair value	[2]	$ 49,448
Shares held (in shares)	[2]	10,961,129
IntraOp Medical Corp. [Member] | Convertible Debt 15 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 3,154
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[2],[3]	500,000	[6],[7]		1,000,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 15 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 3,154
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	1,357
Investments, fair value	[2]	$ 4,511
Shares held (in shares)	[2]	1,000,000
IntraOp Medical Corp. [Member] | Convertible Debt 11 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 677
Shares held (in shares)	[2],[3]	150,000	[6],[7]		500,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 11 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 11 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 2 [Member] | Medical Devices Sector [Member]
Investments, fair value		$ 41
Investments, fair value		$ 45.11
Shares held (in shares)		10,000	[2],[3],[6],[7]		13,000
IntraOp Medical Corp. [Member] | Convertible Debt 2 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 4,100
IntraOp Medical Corp. [Member] | Convertible Debt 2 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	1,764
Investments, fair value	[2]	$ 5,864
Shares held (in shares)	[2]	1,300,000
IntraOp Medical Corp. [Member] | Convertible Debt 16 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 3,158
Shares held (in shares)	[2],[3],[7]	700,000	[6]		500,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 16 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 1,577
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 12 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 4,511
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		500,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 12 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 12 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 3 [Member] | Medical Devices Sector [Member]
Investments, fair value		$ 15.77
Investments, fair value		$ 22.55
Shares held (in shares)	[2],[3],[6],[7]	5,000			5,000
IntraOp Medical Corp. [Member] | Convertible Debt 3 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 3 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	678
Investments, fair value	[2]	$ 2,255
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 17 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 5,864
Shares held (in shares)	[2],[3],[7]	1,300,000	[6]		500,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 17 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 1,577
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 13 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 1,579
Shares held (in shares)	[2],[3]	350,000	[6],[7]		500,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 13 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 3,154
IntraOp Medical Corp. [Member] | Convertible Debt 13 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	1,357
Investments, fair value	[2]	$ 4,511
Shares held (in shares)	[2]	1,000,000
IntraOp Medical Corp. [Member] | Convertible Debt 4 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[2],[3],[7]	500,000	[6]		500,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 4 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 4 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	678
Investments, fair value	[2]	$ 2,255
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 18 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 631
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[3],[7]	500,000	[2],[6]		200,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 18 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 1,577
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 14 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 1,804
Shares held (in shares)	[2],[3]	400,000	[6],[7]		500,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 14 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 14 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 5 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 3,154
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[2],[3],[7]	500,000	[6]		1,000,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 5 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 9,461
IntraOp Medical Corp. [Member] | Convertible Debt 5 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	4,073
Investments, fair value	[2]	$ 13,534
Shares held (in shares)	[2]	3,000,000
IntraOp Medical Corp. [Member] | Convertible Debt 19 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 473
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[2],[3],[7]	500,000	[6]		150,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 19 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 631
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	271
Investments, fair value	[2]	$ 902
Shares held (in shares)	[2]	200,000
IntraOp Medical Corp. [Member] | Convertible Debt 6 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[3],[7]	500,000	[2],[6]		500,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 6 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 3,154
IntraOp Medical Corp. [Member] | Convertible Debt 6 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	1,357
Investments, fair value	[2]	$ 4,511
Shares held (in shares)	[2]	1,000,000
IntraOp Medical Corp. [Member] | Convertible Debt 20 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 1,104
Investments, fair value	[2],[3],[6],[7]	$ 3,383
Shares held (in shares)	[2],[3]	750,000	[6],[7]		350,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 20 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 2,208
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	950
Investments, fair value	[2]	$ 3,158
Shares held (in shares)	[2]	700,000
IntraOp Medical Corp. [Member] | Convertible Debt 7 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 1,261
Investments, fair value	[2],[3],[6],[7]	$ 49,448
Shares held (in shares)	[2],[3],[7]	10,961,129	[6]		400,000	[4]
IntraOp Medical Corp. [Member] | Convertible Debt 7 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,261
IntraOp Medical Corp. [Member] | Convertible Debt 7 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	543
Investments, fair value	[2]	$ 1,804
Shares held (in shares)	[2]	400,000
IntraOp Medical Corp. [Member] | Convertible Debt 21 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 2,208
Investments, fair value	[2],[3],[6],[7]	$ 2,256
Shares held (in shares)	[2],[3]	500,000	[6],[7]		700,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 21 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 473
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	204
Investments, fair value	[2]	$ 677
Shares held (in shares)	[2]	150,000
IntraOp Medical Corp. [Member] | Convertible Debt 8 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 1,577
Investments, fair value	[2],[3],[6],[7]	$ 4,511
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		500,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 8 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 8 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Convertible Debt 22 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 1,104
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	475
Investments, fair value	[2]	$ 1,579
Shares held (in shares)	[2]	350,000
IntraOp Medical Corp. [Member] | Convertible Debt 9 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 2,365
Investments, fair value	[2],[3],[6],[7]	$ 902
Shares held (in shares)	[2],[3]	200,000	[6],[7]		750,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 9 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 2,365
IntraOp Medical Corp. [Member] | Convertible Debt 9 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	1,018
Investments, fair value	[2]	$ 3,383
Shares held (in shares)	[2]	750,000
IntraOp Medical Corp. [Member] | Series C Preferred Stock [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6]	$ 0
Shares held (in shares)	[2],[3]	26,856,187	[6]		26,856,187	[4],[5]
IntraOp Medical Corp. [Member] | Series C Preferred Stock [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 0
IntraOp Medical Corp. [Member] | Series C Preferred Stock [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	26,856,187
IntraOp Medical Corp. [Member] | Convertible Debt 10 [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 3,154
Investments, fair value	[2],[3],[6]	$ 2,256
Shares held (in shares)	[2],[3]	500,000	[6]		1,000,000	[4],[5]
IntraOp Medical Corp. [Member] | Convertible Debt 10 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 1,577
IntraOp Medical Corp. [Member] | Convertible Debt 10 [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	679
Investments, fair value	[2]	$ 2,256
Shares held (in shares)	[2]	500,000
IntraOp Medical Corp. [Member] | Term Note [Member] | Medical Devices Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 9,461
Investments, fair value	[2],[3],[6],[7]	$ 9,022
Shares held (in shares)	[2],[3]	2,000,000	[6],[7]		3,000,000	[4],[5]
IntraOp Medical Corp. [Member] | Term Note [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 6,308
IntraOp Medical Corp. [Member] | Term Note [Member] | Medical Devices Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	2,714
Investments, fair value	[2]	$ 9,022
Shares held (in shares)	[2]	2,000,000
Wrightspeed Inc [Member] | Automotive Sector [Member]
Investments, fair value		$ 0
Investments, fair value	[2],[3],[6],[7]	0
Wrightspeed Inc [Member] | Convertible Debt 1 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	100,000	[6],[7]		4,929,015	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 1 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 1 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	200,000
Wrightspeed Inc [Member] | Convertible Debt 15 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	200,000	[6],[7]		300,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 15 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 15 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	65,000
Wrightspeed Inc [Member] | Convertible Debt 11 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	2,000,000	[6]		1,000,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 11 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 11 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	700,000
Wrightspeed Inc [Member] | Convertible Debt 33 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[6],[7]	3,000
Wrightspeed Inc [Member] | Convertible Debt 33 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	4,929,015
Wrightspeed Inc [Member] | Common Stock [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4]	$ 0
Investments, fair value	[2],[3],[6],[7],[9]	$ 0
Shares held (in shares)	[2],[3]	69,102	[6],[9]		69,102	[4]
Wrightspeed Inc [Member] | Common Stock [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Common Stock [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	69,102
Wrightspeed Inc [Member] | Convertible Debt 2 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[3],[6],[7],[10]	$ 0
Shares held (in shares)	[2],[3]	1,050,000	[6],[7]		750,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 2 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 2 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Convertible Debt 16 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	185,000	[6]		700,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 16 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 16 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	185,000
Wrightspeed Inc [Member] | Convertible Debt 12 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	1,000,000	[6]		1,000,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 12 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 12 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Convertible Debt 34 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[6],[7]	40,000
Wrightspeed Inc [Member] | Convertible Debt 34 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 3 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		900,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 3 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 3 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	100,000
Wrightspeed Inc [Member] | Convertible Debt 17 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	1,200,000	[6]		1,000,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 17 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 17 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 13 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	125,000	[6],[7]		1,000,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 13 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 13 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Convertible Debt 35 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	40,000
Wrightspeed Inc [Member] | Convertible Debt 4 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	135,000	[6],[7]		1,050,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 4 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 4 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	125,000
Wrightspeed Inc [Member] | Convertible Debt 18 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[3],[7]	65,000	[2],[6]		1,000,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 18 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 18 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 14 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	1,400,000	[6],[7]		1,000,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 14 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 14 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Series AA Preferred Stock [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4]	$ 0
Investments, fair value	[2],[3],[6],[9]	$ 0
Shares held (in shares)	[2],[3]	60,733,693	[6],[9]		60,733,693	[4]
Wrightspeed Inc [Member] | Series AA Preferred Stock [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Series AA Preferred Stock [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	60,733,693
Wrightspeed Inc [Member] | Convertible Debt 5 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	700,000	[6],[7]		400,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 5 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 5 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	165,000
Wrightspeed Inc [Member] | Convertible Debt 19 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	2,500	[6]		1,000,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 19 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 19 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 6 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	400,000	[6],[7]		375,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 6 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 6 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	135,000
Wrightspeed Inc [Member] | Convertible Debt 20 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[3],[6],[10]	$ 0
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		200,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 20 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 20 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	300,000
Wrightspeed Inc [Member] | Convertible Debt 7 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	165,000	[6],[7]		400,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 7 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 7 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Convertible Debt 21 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	2,500	[6],[7]		185,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 21 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 21 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	400,000
Wrightspeed Inc [Member] | Convertible Debt 8 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		2,000,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 8 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 8 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Convertible Debt 22 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	250,000	[6],[7]		65,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 22 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 22 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	2,000,000
Wrightspeed Inc [Member] | Convertible Debt 9 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value		$ 0
Shares held (in shares)	[2],[3],[7]	375,000	[6]		1,400,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 9 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 9 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 10 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	400,000	[6]		1,200,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 23 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		250,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 23 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 23 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,400,000
Wrightspeed Inc [Member] | Convertible Debt 24 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	250,000	[6],[7]		250,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 24 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 24 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,200,000
Wrightspeed Inc [Member] | Convertible Debt 25 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	4,929,015	[6],[7]		250,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 25 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 25 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 26 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	250,000	[6],[7]		250,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 26 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[8]	$ 0
Wrightspeed Inc [Member] | Convertible Debt 26 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	250,000
Wrightspeed Inc [Member] | Convertible Debt 27 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	1,000,000	[6],[7]		250,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 27 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,000,000
Wrightspeed Inc [Member] | Convertible Debt 28 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	250,000	[6]		250,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 28 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	1,050,000
Wrightspeed Inc [Member] | Convertible Debt 29 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[7]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3],[7]	750,000	[6]		250,000	[4]
Wrightspeed Inc [Member] | Convertible Debt 29 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	400,000
Wrightspeed Inc [Member] | Convertible Debt 30 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	250,000	[6],[7]		135,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 30 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	375,000
Wrightspeed Inc [Member] | Convertible Debt 31 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	10,000	[6],[7]		165,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 31 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	900,000
Wrightspeed Inc [Member] | Convertible Debt 32 [Member] | Automotive Sector [Member]
Investments, fair value	[2],[3],[4],[5]	$ 0
Investments, fair value	[2],[3],[6],[7]	$ 0
Shares held (in shares)	[2],[3]	900,000	[6],[7]		125,000	[4],[5]
Wrightspeed Inc [Member] | Convertible Debt 32 [Member] | Automotive Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[8]	$ 0
Purchase/merger	[8]	0
Interest	[8]	0
Sales/maturity/expiration	[8]	0
Net realized gain (loss) from security transactions and foreign currency	[8]	0
Net change in unrealized appreciation (depreciation) on investments	[8]	0
Investments, fair value	[8]	$ 0
Shares held (in shares)	[8]	750,000
EQX Capital, Inc [Member] | Equipment Leasing Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 110,227
Investments, fair value		63,157
EQX Capital, Inc [Member] | Common Stock [Member] | Equipment Leasing Sector [Member]
Investments, fair value		55
Investments, fair value	[2],[3],[6],[9]	$ 9
Shares held (in shares)		100,000	[2],[3],[6],[9]		100,000
EQX Capital, Inc [Member] | Common Stock [Member] | Equipment Leasing Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 55
EQX Capital, Inc [Member] | Common Stock [Member] | Equipment Leasing Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	(46)
Investments, fair value	[2]	$ 9
Shares held (in shares)	[2]	100,000
EQX Capital, Inc [Member] | Series A Preferred Stock [Member] | Equipment Leasing Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 110,172
EQX Capital, Inc [Member] | Series A Preferred Stock [Member] | Equipment Leasing Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	(47,024)
Investments, fair value	[2]	$ 63,148
Shares held (in shares)	[2]	1,950,000
UCT Coatings, Inc. [Member] | Common Stock [Member] | Advanced Materials Sector [Member]
Investments, fair value	[3],[4],[10]	$ 299,932
Investments, fair value	[3],[6],[9],[10]	$ 294,836
Shares held (in shares)	[3],[10]	1,500,000	[6],[9]		1,500,000	[4]
UCT Coatings, Inc. [Member] | Common Stock [Member] | Advanced Materials Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value		$ 299,932
UCT Coatings, Inc. [Member] | Common Stock [Member] | Advanced Materials Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger		0
Interest		0
Sales/maturity/expiration		0
Net realized gain (loss) from security transactions and foreign currency		0
Net change in unrealized appreciation (depreciation) on investments		(5,096)
Investments, fair value		$ 294,836
Shares held (in shares)		1,500,000
Hera Systems, Inc. [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 4,200,000
Hera Systems, Inc. [Member] | Convertible Debt 1 [Member] | Aerospace Sector [Member]
Investments, fair value		768,317
Investments, fair value	[2],[3],[6],[7],[9]	$ 2,580,617
Shares held (in shares)		5,359,791	[2],[3],[6],[7],[10]		1,200,000
Hera Systems, Inc. [Member] | Convertible Debt 1 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 3,431,683
Hera Systems, Inc. [Member] | Convertible Debt 1 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	(851,066)
Investments, fair value	[2]	$ 2,580,617
Shares held (in shares)	[2]	5,359,791
Hera Systems, Inc. [Member] | Convertible Debt 2 [Member] | Aerospace Sector [Member]
Investments, fair value		$ 3,431,683
Investments, fair value	[2],[3],[6],[9]	$ 577,772
Shares held (in shares)	[2],[3],[6]	1,200,000			5,359,791	[7]
Hera Systems, Inc. [Member] | Convertible Debt 2 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 768,317
Hera Systems, Inc. [Member] | Convertible Debt 2 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	30,000
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	(190,545)
Investments, fair value	[2]	$ 577,772
Shares held (in shares)	[2]	1,200,000
Hera Systems, Inc. [Member] | Series A Preferred Stock [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 0
Investments, fair value	[2],[3],[6]	$ 0
Shares held (in shares)	[2],[3],[6]	3,642,324	[9]		3,642,324
Hera Systems, Inc. [Member] | Series A Preferred Stock [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 0
Hera Systems, Inc. [Member] | Series A Preferred Stock [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	3,642,324
Hera Systems, Inc. [Member] | Series B Preferred Stock [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6]	$ 0
Investments, fair value	[2],[3],[6],[9]	$ 0
Shares held (in shares)	[2],[3],[6],[9]	7,039,203			7,039,203
Hera Systems, Inc. [Member] | Series B Preferred Stock [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2]	$ 0
Hera Systems, Inc. [Member] | Series B Preferred Stock [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration	[2]	0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	7,039,203
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 0
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration		0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	12,250,000
Hera Systems, Inc. [Member] | Series C Preferred Stock [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 0
Investments, fair value	[2],[3],[6]	$ 0
Shares held (in shares)	[2],[3],[6]	2,650,000			2,650,000	[9]
Hera Systems, Inc. [Member] | Series C Preferred Stock [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 0
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration		0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	2,650,000
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants 2 [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 0
Investments, fair value	[2],[3],[6],[9]	$ 0
Shares held (in shares)	[2],[3],[6],[9]	5,250,000			5,250,000
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants 2 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 0
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration		0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	6,214,922
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants 3 [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 0
Investments, fair value	[2],[3],[6],[9]	$ 0
Shares held (in shares)	[2],[3],[6],[9]	6,214,922			6,214,922
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants 3 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 0
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration		0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	5,250,000
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants 4 [Member] | Aerospace Sector [Member]
Investments, fair value	[2],[3],[6],[9]	$ 0
Investments, fair value	[2],[3],[6],[9]	$ 0
Shares held (in shares)	[2],[3],[6],[9]	700,000			700,000
Hera Systems, Inc. [Member] | Series B Preferred Stock Warrants 4 [Member] | Aerospace Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	[2]	$ 0
Purchase/merger	[2]	0
Interest	[2]	0
Sales/maturity/expiration		0
Net realized gain (loss) from security transactions and foreign currency	[2]	0
Net change in unrealized appreciation (depreciation) on investments	[2]	0
Investments, fair value	[2]	$ 0
Shares held (in shares)	[2]	700,000
Revasum, Inc [Member] | Semiconductor Equipment Sector [Member]
Investments, fair value		$ 31,583.89
Revasum, Inc [Member] | Chess Depositary Interests (CDIs) [Member] | Semiconductor Equipment Sector [Member]
Investments, fair value	[2]	3,862,405
Investments, fair value	[2],[3],[9]	$ 1,010,659
Shares held (in shares)	[2]	39,774,889	[3],[9]		39,774,889
Revasum, Inc [Member] | Chess Depositary Interests (CDIs) [Member] | Semiconductor Equipment Sector [Member] | Investment, Affiliated Issuer, Controlled 1 [Member]
Investments, fair value	[2],[11]	$ 3,862,405
Revasum, Inc [Member] | Chess Depositary Interests (CDIs) [Member] | Semiconductor Equipment Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Purchase/merger	[2],[11]	0
Interest	[2],[11]	0
Sales/maturity/expiration	[2],[11]	0
Net realized gain (loss) from security transactions and foreign currency	[2],[11]	0
Net change in unrealized appreciation (depreciation) on investments	[2],[11]	(2,851,746)
Investments, fair value	[2],[11]	$ 1,010,659
Shares held (in shares)	[2],[11]	39,774,889
[1]Includes warrants whose primary risk exposure is equity contracts.[2]Controlled investments.[3]Fair Value Level 3 security (2770.7% of net assets)[4]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At December 31, 2023, we held $4,797,872 (or 380.7% of net assets) in restricted securities (see Note 2).[5]Security whose interest accrues until maturity however, based on December 31, 2023 valuation no such interest accrued during year ended December 31, 2023.[6]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (see Note 3). At March 31, 2024, we held $3,641,844 (or 2168.8% of net assets) in restricted securities (see Note 2).[7]Security whose interest accrues until maturity however, based on March 31, 2024 valuation no such interest accrued during period ended March 31, 2024.[8]Controlled Investments.[9]Non-income producing security.[10]Affiliated issuer.[11]CDI:CHESS Depositary Interests